{"content":"<li class=\"n-box-item date-title\" data-end=\"1534219199\" data-start=\"1534132800\" data-txt=\"Monday, December 23, 2019\">Monday, August 13, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3382270\" data-ts=\"1534200181\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/THST\" target=\"_blank\">THST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382270-truett-hurstplus-47-sells-wholesale-wine-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Truett-Hurst +47% as it sells wholesale wine business</a></h4><ul>   <li>Wine sales/marketing firm Truett-Hurst (NASDAQ:<a href='https://seekingalpha.com/symbol/THST' title='Truett-Hurst, Inc.'>THST</a>) is <font color='green'>up 47%</font> after hours following word that it's <a href=\"https://seekingalpha.com/pr/17243726-truett-hurst-inc-announces-sale-wholesale-wine-business-precept-brands-llc\" target=\"_blank\">sold its wholesale wine business</a>, to Precept Brands for about $18M in cash.</li>    <li>The business consists of Truett-Hurst's bottled inventory, brands, supplies and bulk wine inventory along with related intellectual property.</li>    <li>Truett-Hurst will keep its direct-to-consumer business, along with Dry Creek Valley Estate in Healdsburg, Calif.</li>    <li>The company should net about $15.9M from the transaction and will continue providing some services to Precept through the current harvest.</li>    <li>It also says Paul Dolan will serve as interim CEO, as current CEO Phillip Hurst will become chief innovation officer at Precept as of Nov. 1.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3382270\" data-linked=\"Truett-Hurst +47% as it sells wholesale wine business\" data-tweet=\"$THST - Truett-Hurst +47% as it sells wholesale wine business https://seekingalpha.com/news/3382270-truett-hurstplus-47-sells-wholesale-wine-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3382270-truett-hurstplus-47-sells-wholesale-wine-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:43 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382266\" data-ts=\"1534199237\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HUYA\" target=\"_blank\">HUYA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382266-huyaminus-2_7-after-q2-beat-light-revenue-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Huya -2.7% after Q2 beat, light revenue guidance</a></h4><ul>   <li>Game streaming firm Huya Broadcasting (NYSE:<a href='https://seekingalpha.com/symbol/HUYA' title='Huya Broadcasting'>HUYA</a>) is <font color='red'>off 2.7%</font> after hours following <a href=\"https://seekingalpha.com/news/3382254-huya-broadcasting-eps-line-beats-revenue\" target=\"_blank\">Q2 earnings</a> where it topped expectations but guided to the light side for Q3 revenues.</li>    <li>Revenues more than doubled to 1.04B yuan (about $156.9M) and the company swung to a net gain of 105.4M (about $15.9M) from a year-ago loss of 9.3M yuan. (Revenues had more than doubled and the company had swung to a gain in the <a href=\"https://seekingalpha.com/news/3361897-huya-plus-5-percent-first-report-shows-swing-gain-doubled-revenues\" target=\"_blank\">company's first public report</a> last quarter.)</li>    <li>Average mobile monthly active users hit 42.7M, up 24.7%. Average overall MAUs hit 91.5M, up 10.8%.</li>    <li>Paying users, meanwhile, rose 40.7% to 3.4M.</li>    <li>Revenue breakout: Live streaming, 991.8M yuan (about $149.9M, and up 124% Y/Y in renminbi terms); advertising and others, 46.5M yuan (about $7M, and up 138%).</li>    <li>Liquidity rose to 5.51B yuan from December's 1.036B yuan due to the May IPO as well as Series B financing from March. Net cash from operations was 105.6M yuan (about $16M), up from a year-ago 79.8M yuan.</li>    <li>For Q3, it's guiding to revenues of 1.19B-1.22B yuan (about $172.7M-$177M, Y/Y growth in renminbi terms of 103.4%-109.1%, on the light side of consensus for 1.22B yuan).</li>    <li><a href=\"http://ir.huya.com/\" target=\"_blank\">Conference call</a> to come at 8 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17243911-huya-reports-second-quarter-2018-unaudited-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3382266\" data-linked=\"Huya -2.7% after Q2 beat, light revenue guidance\" data-tweet=\"$HUYA - Huya -2.7% after Q2 beat, light revenue guidance https://seekingalpha.com/news/3382266-huyaminus-2_7-after-q2-beat-light-revenue-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3382266-huyaminus-2_7-after-q2-beat-light-revenue-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382262\" data-ts=\"1534198515\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SVT\" target=\"_blank\">SVT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382262-servotronics-reports-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Servotronics reports Q2 results</a></h4><ul><li>Servotronics (NYSEMKT:<a href='https://seekingalpha.com/symbol/SVT' title='Servotronics, Inc'>SVT</a>): Q2 EPS of $0.30</li><li>Revenue of $11.95M (+24.2% Y/Y)</li><li>Shares <font color='green'>+9.27%</font> AH.</li><li><a href='https://seekingalpha.com/pr/17243919-servotronics-inc-announces-second-quarter-results-period-ended-june-30-2018'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3382262\" data-linked=\"Servotronics reports Q2 results\" data-tweet=\"$SVT - Servotronics reports Q2 results https://seekingalpha.com/news/3382262-servotronics-reports-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3382262-servotronics-reports-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:15 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382261\" data-ts=\"1534198366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YY\" target=\"_blank\">YY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382261-yyplus-1_5-q2-profits-revenues-jump\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YY +1.5% as Q2 profits, revenues jump</a></h4><ul>   <li><a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a> is <font color='green'>up 1.5%</font> in after-hours Nasdaq trading after beating on top and bottom lines in its <a href=\"https://seekingalpha.com/news/3382257-yy-beats-0_26-beats-revenue\" target=\"_blank\">Q2 earnings</a>, despite guiding to the low side for Q3 revenues.</li>    <li>Revenues grew 45% to 3.77B yuan (about $570.2M) and non-GAAP profit rose 52% to 873.2M yuan (about $132M).</li>    <li>Mobile live streaming monthly active users rose 21% to 80.2M; paying users also rose 21%, to 6.9M.</li>    <li>Revenue breakout: Live streaming revenues, 3.56B yuan ($538M, up 50% in renminbi terms); other, 213.6M yuan ($32.3M, down 9.4%).</li>    <li>Cash and equivalents came to 3.56B yuan (about $538.4M), and short-term deposits were 9.5B yuan (about $1.44B); net cash from operations for the quarter was 738.3M yuan (about $111.6M).</li>    <li>For Q3, it's guiding to net revenues of 3.89B-4.02B yuan (Y/Y growth of 25.8%-30%, and about $564.5M-$583.3M, light of expectations for $589.3M).</li>    <li><a href=\"http://ir.yy.com/\" target=\"_blank\">Conference call</a> to come at 9 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17243913-yy-reports-second-quarter-2018-unaudited-financial-results\" target=\"_blank\">Press release</a></li>  </ul><div class=\"tiny-share-widget\" data-id=\"3382261\" data-linked=\"YY +1.5% as Q2 profits, revenues jump\" data-tweet=\"$YY - YY +1.5% as Q2 profits, revenues jump https://seekingalpha.com/news/3382261-yyplus-1_5-q2-profits-revenues-jump?source=tweet\" data-url=\"https://seekingalpha.com/news/3382261-yyplus-1_5-q2-profits-revenues-jump\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>74&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382247\" data-ts=\"1534196067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYX\" target=\"_blank\">PYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382247-after-hours-gainers-losers-08-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers (08/13/2018)</a></h4><ul><li><b>Top Gainers:</b> AOI <font color='green'>+5.4%</font>. <a href='https://seekingalpha.com/symbol/GTE' title='Gran Tierra Energy, Inc'>GTE</a>&nbsp;<font color='green'>+5.0%.</font>&nbsp;<a href='https://seekingalpha.com/symbol/CSIQ' title='Canadian Solar Inc.'>CSIQ</a>&nbsp;<font color='green'>+3.9%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/AWX' title='Avalon Holdings Corporation'>AWX</a> <font color='green'>+2.7%</font>. <a href='https://seekingalpha.com/symbol/INFI' title='Infinity Pharmaceuticals, Inc.'>INFI</a> <font color='green'>+2.4%</font>.</li><li><b>Top Losers:</b> <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='red'>-23.8%</font>. <a href='https://seekingalpha.com/symbol/SWCH' title='Switch, Inc.'>SWCH</a>&nbsp;<font color='red'>-19.1%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/VIPS' title='Vipshop Holdings'>VIPS</a>&nbsp;<font color='red'>-10.5%</font>.&nbsp;<a href='https://seekingalpha.com/symbol/SAIL' title='SailPoint Technologies'>SAIL</a> <font color='red'>-3.2%</font>. <a href='https://seekingalpha.com/symbol/SFM' title='Sprouts Farmers Market'>SFM</a> <font color='red'>-3.1%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382247\" data-linked=\"After Hours Gainers / Losers (08/13/2018)\" data-tweet=\"$PYX $PYX $GTE - After Hours Gainers / Losers (08/13/2018) https://seekingalpha.com/news/3382247-after-hours-gainers-losers-08-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3382247-after-hours-gainers-losers-08-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:34 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382229\" data-ts=\"1534194250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PRO\" target=\"_blank\">PRO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382229-pros-commences-follow-on-offering-of-4m-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">PROS commences follow-on offering of 4M shares</a></h4><ul><li>        PROS (NYSE:<a href='https://seekingalpha.com/symbol/PRO' title='PROS Holdings, Inc.'>PRO</a>) <a href=\"https://seekingalpha.com/pr/17243777-pros-announces-launch-proposed-follow-offering-common-stock\" target=\"_blank\">commences</a> a proposed follow-on public offering of 4M shares of common stock with 3.8M coming from PROS and 200K from selling shareholders.</li><li>               Underwriters will be granted an option to purchase up to 600K additional shares (400K from PROS and 200K from selling shareholders).&nbsp;</li><li>               PROS shares are flat premarket at $39.77.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3382229\" data-linked=\"PROS commences follow-on offering of 4M shares\" data-tweet=\"$PRO - PROS commences follow-on offering of 4M shares https://seekingalpha.com/news/3382229-pros-commences-follow-on-offering-of-4m-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3382229-pros-commences-follow-on-offering-of-4m-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382226\" data-ts=\"1534193810\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAIL\" target=\"_blank\">SAIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382226-sailpoint-files-for-12_5m-common-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SailPoint files for 12.5M common stock offering</a></h4><ul><li>        SailPoint (NYSE:<a href='https://seekingalpha.com/symbol/SAIL' title='SailPoint Technologies'>SAIL</a>) <a href=\"https://seekingalpha.com/filing/4135916\" target=\"_blank\">files</a> for a 12.5M common stock offering by selling shareholders.</li><li>               SailPoint won&rsquo;t receive any of the proceeds from the sale.&nbsp;</li><li>                  SailPoint shares are<font color='red'> down 2.4%</font>&nbsp;aftermarket to $27.75.&nbsp;&nbsp;&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3382226\" data-linked=\"SailPoint files for 12.5M common stock offering\" data-tweet=\"$SAIL - SailPoint files for 12.5M common stock offering https://seekingalpha.com/news/3382226-sailpoint-files-for-12_5m-common-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3382226-sailpoint-files-for-12_5m-common-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382222\" data-ts=\"1534193425\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARQL\" target=\"_blank\">ARQL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382222-arqules-arq-531-shows-encouraging-action-in-preclinical-studies-shares-up-2-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ArQule&#39;s ARQ 531 shows encouraging action in preclinical studies; shares up 2% after hours</a></h4><ul><li>ArQule (NASDAQ:<a href='https://seekingalpha.com/symbol/ARQL' title='ArQule, Inc.'>ARQL</a>) is up&nbsp;<font color='green'>2%</font>&nbsp;after hours on light volume in response to its <a href=\"https://seekingalpha.com/pr/17243729-arqule-announces-publication-preclinical-data-arq-531-reversible-inhibitor-wild-type-mutant\" target=\"_blank\">announcement </a>of positive data from preclinical studies of Bruton's tyrosine kinase &#40;BTK&#41; inhibitor ARQ 531. The results were just published in <em>Cancer Discovery</em>.</li><li>The company says it demonstrated inhibition of both wild type and mutant BTK in blood cancer models which may expand the patient population beyond those with a C481S mutation.</li><li>ARQ 531 showed similar inhibition of wild type BTK to AbbVie's (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) IMBRUVICA (ibrutinib), but exhibited greater inhibition for mutant BTK.</li><li>No guidance is provided as to when ARQ 531 will enter the clinic.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382222\" data-linked=\"ArQule&#39;s ARQ 531 shows encouraging action in preclinical studies; shares up 2% after hours\" data-tweet=\"$ARQL $ARQL $ABBV - ArQule&#39;s ARQ 531 shows encouraging action in preclinical studies; shares up 2% after hours https://seekingalpha.com/news/3382222-arqules-arq-531-shows-encouraging-action-in-preclinical-studies-shares-up-2-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3382222-arqules-arq-531-shows-encouraging-action-in-preclinical-studies-shares-up-2-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382206\" data-ts=\"1534192554\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SWCH\" target=\"_blank\">SWCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382206-switchminus-17_7-on-q2-miss-trimmed-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Switch -17.7% on Q2 miss, trimmed guidance</a></h4><ul>   <li>Switch (NYSE:<a href='https://seekingalpha.com/symbol/SWCH' title='Switch, Inc.'>SWCH</a>) is <font color='red'>off 17.7%</font> in late trading after posting record <a href=\"https://seekingalpha.com/news/3382195-switch-misses-0_02-misses-revenue\" target=\"_blank\">Q2 earnings</a> that nonetheless lagged analyst expectations as the company's sales pipeline swelled with longer timelines, and the company trimmed 2018 guidance.</li>    <li>Revenue rose by double digits to a record $102.16M, but short of expectations for $102.8M. Operating income fell 33%, largely due ot the impact of $8.2M in equity-based compensation expense.</li>    <li>Net income fell to $9.5M from $15M; EBITDA of $50.3M was up from $46.8M, but trailed consensus for $52.8M.</li>    <li>For the full year -- and taking into account deals closing later than anticipated -- it's guiding to total revenue of $405M-$408M (down from $423M-$440M and light of consensus for $428.3M); EBITDA of $197M-$200M (down from $216M-$224M and below consensus for $216.1M); and capex of $260M-$310M, unchanged.</li>    <li><a href=\"https://investors.switch.com/\" target=\"_blank\">Conference call</a> to come at 5 p.m. ET.</li>   <li><a href=\"https://seekingalpha.com/pr/17243815-switch-announces-second-quarter-2018-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3382206\" data-linked=\"Switch -17.7% on Q2 miss, trimmed guidance\" data-tweet=\"$SWCH - Switch -17.7% on Q2 miss, trimmed guidance https://seekingalpha.com/news/3382206-switchminus-17_7-on-q2-miss-trimmed-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3382206-switchminus-17_7-on-q2-miss-trimmed-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382198\" data-ts=\"1534192165\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ADUS\" target=\"_blank\">ADUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382198-addus-homecare-readies-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Addus HomeCare readies stock offering</a></h4><ul><li>Addus HomeCare (NASDAQ:<a href='https://seekingalpha.com/symbol/ADUS' title='Addus HomeCare Corporation'>ADUS</a>) <a href=\"https://seekingalpha.com/pr/17243782-addus-homecare-announces-public-offering-common-stock\" target=\"_blank\">commences</a> a public offering of ~1.1M shares of common stock. Current investor Eos Capital Partners III L.P. is also offering ~1.0M shares. Underwriters over-allotment is an additional 315K shares. Price and terms have yet to be released.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382198\" data-linked=\"Addus HomeCare readies stock offering\" data-tweet=\"$ADUS - Addus HomeCare readies stock offering https://seekingalpha.com/news/3382198-addus-homecare-readies-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3382198-addus-homecare-readies-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:29 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382196\" data-ts=\"1534192126\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VERI\" target=\"_blank\">VERI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382196-veritoneminus-12-revenues-profits-fall-short\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Veritone -12% as revenues, profits fall short</a></h4><ul>   <li>Veritone (NASDAQ:<a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a>) has <font color='red'>slid 12%</font> in postmarket trading after it posted a miss on top and bottom lines in its <a href=\"https://seekingalpha.com/news/3382159-veritone-misses-0_03-misses-revenue\" target=\"_blank\">Q2 earnings</a></li>    <li>Revenues grew just 2%. Net loss narrowed to $14.3M from a year-ago loss of $25M, but EPS was still short of expectations. Monthly recurring revenue rose 62% to $214,000.</li>    <li>EBITDA was -$11M, short of an expected -$10.4M.</li>    <li>Customers, meanwhile, grew 126% to 86, and accounts were up 270% to 625. Third-party cognitive engines grew 210% to 214, and hours of video/audio processed rose 523% to 2.729M.</li>    <li>Liquidity was $78.2M against no long-term debt.</li>    <li>For Q3, in its key performance indicators, the company is targeting adding nine AI customers to reach 95; to add 30 AI accounts to bring that total to 655; add 20 third-party cognitive engines integrated with aiWARE to bring that total to 234; and process 2.7M total hours of video/audio on aiWARE.</li>    <li><a href=\"http://investors.veritone.com\" target=\"_blank\">Conference call</a> to come at 4:30 p.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17243754-veritone-reports-financial-results-second-quarter-2018\" target=\"_blank\">Press release</a></li>   </ul><div class=\"tiny-share-widget\" data-id=\"3382196\" data-linked=\"Veritone -12% as revenues, profits fall short\" data-tweet=\"$VERI - Veritone -12% as revenues, profits fall short https://seekingalpha.com/news/3382196-veritoneminus-12-revenues-profits-fall-short?source=tweet\" data-url=\"https://seekingalpha.com/news/3382196-veritoneminus-12-revenues-profits-fall-short\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382185\" data-ts=\"1534191841\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GEMP\" target=\"_blank\">GEMP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382185-gemphire-q2-cash-28m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Gemphire Q2 cash at $28M</a></h4><ul><li>Gemphire Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a>) <a href=\"https://seekingalpha.com/pr/17243740-gemphire-therapeutics-reports-second-quarter-2018-financial-results-provides-corporate-update\" target=\"_blank\">Q2 highlights</a>:</li><li>Operating expenses: $6.5M (-38%); net loss: ($6.7M) (-36%).</li><li>Cash balance of $28M should be sufficient to fund operations into Q4 2019.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382185\" data-linked=\"Gemphire Q2 cash at $28M\" data-tweet=\"$GEMP - Gemphire Q2 cash at $28M https://seekingalpha.com/news/3382185-gemphire-q2-cash-28m?source=tweet\" data-url=\"https://seekingalpha.com/news/3382185-gemphire-q2-cash-28m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382182\" data-ts=\"1534191680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MXWL\" target=\"_blank\">MXWL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382182-maxwell-tech-ceo-cfo-directors-disclose-public-offering-purchases\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maxwell Tech CEO, CFO, directors disclose public offering purchases</a></h4><ul><li>        Maxwell Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/MXWL' title='Maxwell Technologies, Inc.'>MXWL</a>) CEO Franz Fink <a href=\"https://seekingalpha.com/filing/4135558\" target=\"_blank\">discloses</a> acquiring 400K shares at an average price of $3.25 during the company&rsquo;s public offering, which closed August 10.</li><li>               CFO David Lyle <a href=\"https://seekingalpha.com/filing/4135575\" target=\"_blank\">acquired</a> 30,700 shares, director Burkhard Goeschel <a href=\"https://seekingalpha.com/filing/4135577\" target=\"_blank\">acquired</a> 46K shares, and director Jorg Buchheim <a href=\"https://seekingalpha.com/filing/4135566\" target=\"_blank\">acquired</a> 169,200 shares at the same price and circumstance.&nbsp;</li><li>                  Maxwell Tech shares are<font color='green'> up 2.7%&nbsp;</font>aftermarket to $3.49. </li><li>Previously: <a href=\"https://seekingalpha.com/news/3379772-maxwell-technologies-commences-public-offering-6m-shares\" target=\"_blank\">Maxwell Technologies commences public offering of 6M shares</a> (Aug. 7)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3380165-maxwell-technologies-prices-public-offering\" target=\"_blank\">Maxwell Technologies prices public offering</a> (Aug. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3382182\" data-linked=\"Maxwell Tech CEO, CFO, directors disclose public offering purchases\" data-tweet=\"$MXWL - Maxwell Tech CEO, CFO, directors disclose public offering purchases https://seekingalpha.com/news/3382182-maxwell-tech-ceo-cfo-directors-disclose-public-offering-purchases?source=tweet\" data-url=\"https://seekingalpha.com/news/3382182-maxwell-tech-ceo-cfo-directors-disclose-public-offering-purchases\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:21 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382167\" data-ts=\"1534191248\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VIPS\" target=\"_blank\">VIPS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382167-vipshopminus-8_9-growth-falls-short-of-targets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vipshop -8.9% as growth falls short of targets</a></h4><ul>   <li>Vipshop Holdings (NYSE:<a href='https://seekingalpha.com/symbol/VIPS' title='Vipshop Holdings'>VIPS</a>) is <font color='red'>8.9% lower</font> after hours following <a href=\"https://seekingalpha.com/news/3382155-vipshop-holdings-misses-0_01-beats-revenue\" target=\"_blank\">Q2 earnings</a> where revenues increase 18% but fell short of analyst expectations in renminbi terms.</li>    <li>Total net revenue was 20.7B yuan (about $3.1B), short of consensus for 21.2B yuan. Gross profit increased by 4.8% to 4B yuan (about $611.1M).</li>    <li>Net income attributable to shareholders came to about 0.84 yuan/ADS, short of consensus for 0.93 yuan.</li>    <li>Active customers rose by 6% Y/Y to 29.8M; total orders were up by 31% to 111.3M.</li>    <li>Meanwhile average revenue per customer rose by about 12% over the prior year.</li>    <li>At quarter's end, cash, equivalents and restricted cash was 6.4B yuan (about $971.2M), and short-term investments were 2.1B yuan (about $312.7M). Cash used in operations was 502.2M yuan (about $75.9M) and free cash flow was -902.8M yuan (about -$136.4M).</li>    <li><a href=\"http://ir.vip.com/\" target=\"_blank\">Conference call</a> to come tomorrow at 8 a.m. ET.</li>    <li><a href=\"https://seekingalpha.com/pr/17243765-vipshop-reports-unaudited-second-quarter-2018-financial-results\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3382167\" data-linked=\"Vipshop -8.9% as growth falls short of targets\" data-tweet=\"$VIPS - Vipshop -8.9% as growth falls short of targets https://seekingalpha.com/news/3382167-vipshopminus-8_9-growth-falls-short-of-targets?source=tweet\" data-url=\"https://seekingalpha.com/news/3382167-vipshopminus-8_9-growth-falls-short-of-targets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382137\" data-ts=\"1534190092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSTC\" target=\"_blank\">BSTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382137-biospecifics-tech-adds-to-q2-results-stoked-rally-up-11\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioSpecifics Tech adds to Q2 results-stoked rally, up 11%</a></h4><ul><li>Thinly traded micro cap BioSpecifics Technologies (<a href='https://seekingalpha.com/symbol/BSTC' title='BioSpecifics Technologies Corp.'>BSTC</a> <font color='green'>+11%</font>) is up on more than 20% higher volume, albeit on turnover of only 30K shares. The stock has rallied almost&nbsp;<font color='green'>15%</font>&nbsp;since releasing <a href=\"https://seekingalpha.com/pr/17241173-biospecifics-technologies-corp-reports-second-quarter-2018-financial-results\" target=\"_blank\">Q2 results </a>last Thursday.</li><li>Royalty revenue increased 9% to $7.1M primarily due to increased royalties from XIAFLEX from partner Endo Pharmaceuticals. Licensing revenue jumped eight-fold to $35.3M due to a change in accounting treatment (may not be comparable, though).</li><li>Net income was up 65% to $4.3M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382137\" data-linked=\"BioSpecifics Tech adds to Q2 results-stoked rally, up 11%\" data-tweet=\"$BSTC - BioSpecifics Tech adds to Q2 results-stoked rally, up 11% https://seekingalpha.com/news/3382137-biospecifics-tech-adds-to-q2-results-stoked-rally-up-11?source=tweet\" data-url=\"https://seekingalpha.com/news/3382137-biospecifics-tech-adds-to-q2-results-stoked-rally-up-11\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:54 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382132\" data-ts=\"1534189003\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WKHS\" target=\"_blank\">WKHS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382132-workhorse-updates-on-share-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Workhorse updates on share offering</a></h4><ul> <li>Workhorse Group (<a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='green'>+4.4%</font>) announces that it closed on its previously announced 9M share offering at a price of $1.15 per share.</li><li>The company has also granted the underwriter a 45-day over-allotment option to purchase up to 1.35M additional shares at the public offering price.</li> <li>National Securities Corporation acted as sole book running manager for the offering.</li> <li>Workhorse says it intends to use the net proceeds from the offering primarily for inventory, working capital and general corporate purposes. Gross proceeds from the offering were ~$10.35M.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17243664-workhorse-group-inc-closes-10_35-million-public-offering-common-stock\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3382132\" data-linked=\"Workhorse updates on share offering\" data-tweet=\"$WKHS - Workhorse updates on share offering https://seekingalpha.com/news/3382132-workhorse-updates-on-share-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3382132-workhorse-updates-on-share-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382131\" data-ts=\"1534188439\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLSN\" target=\"_blank\">NLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382131-nielsen-launches-auto-cloud-offering-j-d-power\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nielsen launches Auto Cloud offering with J.D. Power</a></h4><ul>   <li>Nielsen (NYSE:<a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings N.V.'>NLSN</a>) is <font color='green'>up 10.9%</font> today in a regular session running at five times normal share volume after Elliott Management <a href=\"https://seekingalpha.com/news/3381971-elliott-confirms-active-stake-nielsen-sale-push\" target=\"_blank\">confirmed an activist stake</a> in the company, with an eye to pressing for a sale.</li>    <li>The company today also launched its <a href=\"https://seekingalpha.com/pr/17243331-j-d-power-nielsen-transform-auto-advertising-launch-nielsen-auto-cloud\" target=\"_blank\">Nielsen Auto Cloud</a> offering, a team-up with J.D. Power to get audience data to automotive advertisers, agencies and media owners.</li>    <li>The new product lets marketers target audiences based on criteria including car features/styles, buying stage and brand affinities as well as media engagement, geo-location and device type.</li>    <li>The offering covers TV and digital and has built-in campaign measurement and optimization.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3382131\" data-linked=\"Nielsen launches Auto Cloud offering with J.D. Power\" data-tweet=\"$NLSN - Nielsen launches Auto Cloud offering with J.D. Power https://seekingalpha.com/news/3382131-nielsen-launches-auto-cloud-offering-j-d-power?source=tweet\" data-url=\"https://seekingalpha.com/news/3382131-nielsen-launches-auto-cloud-offering-j-d-power\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:27 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382130\" data-ts=\"1534188225\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382130-cowen-names-nvidia-top-pick-on-gaming-chips\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen names Nvidia a &quot;top pick&quot; on gaming chips</a></h4><ul><li>        Cowen <a href=\"https://www.cnbc.com/2018/08/13/cowen-makes-nvidia-a-top-pick-because-of-the-chipmakers-upcoming-ch.html\" target=\"_blank\">names</a> Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) a &ldquo;top pick&rdquo; because of its upcoming Turing gaming chips.</li><li>               Analyst Matthew Ramsay: &ldquo;We see a favorable setup as we expect well-documented choppiness in the gaming channel to be offset by continued robust datacenter demand and backlog. We see little risk to near-term numbers from crypto.&rdquo;&nbsp;</li><li>                  Rating reiterated at Outperform with a $325 price target, a 28% upside to Friday&rsquo;s close.    </li><li>               Ramsay raises his adjusted EPS estimate for Nvidia&rsquo;s Q2 from $1.82 to $1.85 (consensus: $1.82).&nbsp;</li><li>               Nvidia reports earnings on Thursday.&nbsp;</li><li>               Nvidia shares are&nbsp;<font color='green'>up 0.6%</font>&nbsp;to $256.29.&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3382130\" data-linked=\"Cowen names Nvidia a &quot;top pick&quot; on gaming chips\" data-tweet=\"$NVDA - Cowen names Nvidia a &quot;top pick&quot; on gaming chips https://seekingalpha.com/news/3382130-cowen-names-nvidia-top-pick-on-gaming-chips?source=tweet\" data-url=\"https://seekingalpha.com/news/3382130-cowen-names-nvidia-top-pick-on-gaming-chips\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>27&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382129\" data-ts=\"1534187822\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ETH-USD\" target=\"_blank\">ETH-USD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382129-ether-plunge-leads-cryptos-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ether plunge leads cryptos lower</a></h4><ul><li>\"Investors are increasingly disillusioned with tokens and ICOs, most of which <a href=\"https://www.bloomberg.com/news/articles/2018-08-13/ether-tumbles-as-concern-increases-that-icos-are-cashing-out?utm_source=twitter&amp;utm_campaign=socialflow-organic&amp;utm_medium=social&amp;utm_content=crypto\" target=\"_blank\">have been launched on</a> top of Ethereum (<a href='https://seekingalpha.com/symbol/ETH-USD' title='Ethereum USD'>ETH-USD</a>), and we&rsquo;re seeing this play out in the market with continued downward price pressure,\" says Blockchain Capital's Spencer Bogart.</li><li>Ether is&nbsp;<font color='red'>lower by 10.2%</font>&nbsp;today to $286. It topped $1K back in February.</li><li>Bitcoin (<a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>)&nbsp;<font color='red'>down 1.5%&nbsp;</font>to 6,228; Ripple (<a href='https://seekingalpha.com/symbol/XRP-USD' title='XRP USD'>XRP-USD</a>)&nbsp;<font color='red'>-4.8%</font>&nbsp;to $0.28, Bitcoin Cash (<a href='https://seekingalpha.com/symbol/BCH-USD' title='Bitcoin Cash USD'>BCH-USD</a>)<font color='red'> -6.3%</font>&nbsp;to $535, Litecoin (<a href='https://seekingalpha.com/symbol/LTC-USD' title='Litecoin USD'>LTC-USD</a>)&nbsp;<font color='red'>-5.3%</font>&nbsp;to $56.23.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/BTLLF' title='Interbit Ltd.'>OTCPK:BTLLF</a> <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>, <a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>, <a href='https://seekingalpha.com/symbol/ETH-USD' title='Ethereum USD'>ETH-USD</a>, <a href='https://seekingalpha.com/symbol/XRP-USD' title='XRP USD'>XRP-USD</a>, <a href='https://seekingalpha.com/symbol/BCH-USD' title='Bitcoin Cash USD'>BCH-USD</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3382129\" data-linked=\"Ether plunge leads cryptos lower\" data-tweet=\"$ETH-USD $ETH-USD $BTC-USD - Ether plunge leads cryptos lower https://seekingalpha.com/news/3382129-ether-plunge-leads-cryptos-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3382129-ether-plunge-leads-cryptos-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>87&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382127\" data-ts=\"1534187592\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DB\" target=\"_blank\">DB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382127-deutsche-bank-bank-of-ozark-fall-after-downgrades-first-western-financial-rises-on-outperform\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deutsche Bank, Bank of Ozark fall after downgrades; First Western Financial rises on outperform rating</a></h4><ul><li>Deutsche Bank (NYSE:<a href='https://seekingalpha.com/symbol/DB' title='Deutsche Bank AG'>DB</a>)<font color='red'> falls 2.75%</font>&nbsp;after it was <a href=\"https://www.marketbeat.com/ratings/USA/latest/\" target=\"_blank\">downgraded to underperform</a> from neutral by Bank of America.</li><li>Bank of Ozark (NASDAQ:<a href='https://seekingalpha.com/symbol/OZK' title='Bank OZK'>OZK</a>)<font color='red'> -2.22%</font>&nbsp;as its cut to underweight from overweight by Barclays</li><li>First Western Financial&nbsp;<font color='green'>rises 2.96%</font>&nbsp;Keefe, Bruyette &amp; Woods starts coverage with an outperform rating.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382127\" data-linked=\"Deutsche Bank, Bank of Ozark fall after downgrades; First Western Financial rises on outperform rating\" data-tweet=\"$DB $DB $OZK - Deutsche Bank, Bank of Ozark fall after downgrades; First Western Financial rises on outperform rating https://seekingalpha.com/news/3382127-deutsche-bank-bank-of-ozark-fall-after-downgrades-first-western-financial-rises-on-outperform?source=tweet\" data-url=\"https://seekingalpha.com/news/3382127-deutsche-bank-bank-of-ozark-fall-after-downgrades-first-western-financial-rises-on-outperform\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:13 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382120\" data-ts=\"1534186590\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABIL\" target=\"_blank\">ABIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382120-technology-top-5-gainers-losers-of-2_55-pm-08-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 2.55 PM (08/13/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+62%</font>. <a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf'>DBD</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings N.V.'>NLSN</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/VERI' title='Veritone'>VERI</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/BOXL' title='Boxlight'>BOXL</a> <font color='green'>+10%</font>.</li>     <li><strong>Losers: </strong><a href='https://seekingalpha.com/symbol/DTRM' title='Determine, Inc.'>OTC:DTRM</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/RMNI' title='Rimini Street'>RMNI</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/NH' title='NantHealth'>NH</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/SITO' title='SITO Mobile, Ltd.'>SITO</a> <font color='red'>-9%</font>.</li> &nbsp;     &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3382120\" data-linked=\"Technology - Top 5 Gainers / Losers as of 2.55 PM (08/13/2018)\" data-tweet=\"$ABIL $ABIL $DBD - Technology - Top 5 Gainers / Losers as of 2.55 PM (08/13/2018) https://seekingalpha.com/news/3382120-technology-top-5-gainers-losers-of-2_55-pm-08-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3382120-technology-top-5-gainers-losers-of-2_55-pm-08-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382118\" data-ts=\"1534185374\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TRUE\" target=\"_blank\">TRUE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382118-da-davidson-raises-truecar-target-to-slight-downside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DA Davidson raises its TrueCar target to slight downside</a></h4><ul><li>           DA Davidson <a href=\"https://www.streetinsider.com/Analyst+PT+Change/TrueCar+%28TRUE%29+PT+Raised+to+%2412.75+at+DA+Davidson/14503504.html\" target=\"_blank\">raises</a> its TrueCar (NASDAQ:<a href='https://seekingalpha.com/symbol/TRUE' title='TrueCar, Inc'>TRUE</a>) price target from $10 to $12.75, a slight downside to Friday&rsquo;s $12.79 close, and maintains a Neutral rating. </li><li> TrueCar shares are&nbsp;<font color='red'>down 1.4%</font>&nbsp;to $12.61. &nbsp;&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3382118\" data-linked=\"DA Davidson raises its TrueCar target to slight downside\" data-tweet=\"$TRUE - DA Davidson raises its TrueCar target to slight downside https://seekingalpha.com/news/3382118-da-davidson-raises-truecar-target-to-slight-downside?source=tweet\" data-url=\"https://seekingalpha.com/news/3382118-da-davidson-raises-truecar-target-to-slight-downside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:36 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382117\" data-ts=\"1534184589\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XGTI\" target=\"_blank\">XGTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382117-xg-technologyplus-8-on-cogent-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XG Technology +8% on Cogent deal</a></h4><ul><li>        XG Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/XGTI' title='xG Technology, Inc.'>XGTI</a>) <a href=\"https://seekingalpha.com/pr/17243422-vislink-enters-strategic-partnership-cogent-technologies\" target=\"_blank\">announces</a> a strategic cooperation between Vislink and Cogent Technologies that gives Vislink exclusive rights to help promote and sell Cogent products and solutions in all regions outside of China.</li><li>               Cogent is mainly engaged in R&amp;D and sales of transmission products including 4G portable transmission devices, bonded cellular solutions, and wireless microwave transmission products.&nbsp;&nbsp;</li><li>               XG Technology shares are&nbsp;<font color='green'>up 7.9%</font>&nbsp;to $0.62.&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3382117\" data-linked=\"XG Technology +8% on Cogent deal\" data-tweet=\"$XGTI $XGTI-OLD - XG Technology +8% on Cogent deal https://seekingalpha.com/news/3382117-xg-technologyplus-8-on-cogent-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3382117-xg-technologyplus-8-on-cogent-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382114\" data-ts=\"1534183966\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CERN\" target=\"_blank\">CERN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382114-hedgeye-names-active-short-20-downside-cernminus-1_5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hedgeye names active short with 20% downside; CERN -1.5%</a></h4><ul><li>        Hedgeye names Cerner (NASDAQ:<a href='https://seekingalpha.com/symbol/CERN' title='Cerner Corporation'>CERN</a>) an active short with a 20% downside over the next six months.</li><li>               Hedgeye sees the 2019 consensus estimates as far too high and thinks preliminary guidance will disappoint. The firm also thinks Q4 bookings could be down more than 30%.&nbsp;</li><li>               Source: StreetAccount.&nbsp;</li><li>               Cerner shares are&nbsp;<font color='red'>down 1.5%</font>&nbsp;to $64.19. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3382114\" data-linked=\"Hedgeye names active short with 20% downside; CERN -1.5%\" data-tweet=\"$CERN - Hedgeye names active short with 20% downside; CERN -1.5% https://seekingalpha.com/news/3382114-hedgeye-names-active-short-20-downside-cernminus-1_5?source=tweet\" data-url=\"https://seekingalpha.com/news/3382114-hedgeye-names-active-short-20-downside-cernminus-1_5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382113\" data-ts=\"1534183819\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOG\" target=\"_blank\">HOG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382113-harley-davidson-teed-up-political-hot-potato\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Harley-Davidson teed up as political hot potato</a></h4><ul><li>Harley-Davidson (NYSE:<a href='https://seekingalpha.com/symbol/HOG' title='Harley-Davidson, Inc.'>HOG</a>) sits right smack in the middle of a Senate race in Wisconsin after President Trump doubled down on his calls to boycott Harley-Davidson (<a href='https://seekingalpha.com/symbol/HOG' title='Harley-Davidson, Inc.'>HOG</a> <font color='red'>-4.2%</font>) via Twitter.</li><li>GOP U.S. Senate candidate Kevin Nicholson <a href=\"https://www.jsonline.com/story/news/politics/elections/2018/08/13/scott-walker-caught-between-donald-trump-and-harley-davidson/975730002/\" target=\"_blank\">argued</a> against a boycott of the Milwaukee-based company, while Governor Scott Walker and Nicholson primary opponent&nbsp;state Sen. Leah Vukmi have yet to go public with their comments.</li><li>Harley is shifting production out of the U.S. due to higher costs associated with tariffs and increasing demand in some international markets.</li><li>Shares of HOG are&nbsp;<font color='red'>down 4.35%</font>&nbsp;to $41.37, their lowest level since late July.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382113\" data-linked=\"Harley-Davidson teed up as political hot potato\" data-tweet=\"$HOG - Harley-Davidson teed up as political hot potato https://seekingalpha.com/news/3382113-harley-davidson-teed-up-political-hot-potato?source=tweet\" data-url=\"https://seekingalpha.com/news/3382113-harley-davidson-teed-up-political-hot-potato\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:10 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382110\" data-ts=\"1534183255\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AG\" target=\"_blank\">AG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382110-energy-materials-top-gainers-losers-of-2-00-pm-08-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 PM (08/13/2018)</a></h4><ul><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/UPL' title='Ultra Petroleum Corp.'>UPL</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/PEIX' title='Pacific Ethanol, Inc.'>PEIX</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/TAT' title='TransAtlantic Petroleum Ltd.'>TAT</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/ALO' title='Alio Gold Inc'>ALO</a> <font color='red'>-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382110\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 PM (08/13/2018)\" data-tweet=\"$AG $AG $UPLC - Energy/Materials - Top Gainers / Losers as of 2:00 PM (08/13/2018) https://seekingalpha.com/news/3382110-energy-materials-top-gainers-losers-of-2-00-pm-08-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3382110-energy-materials-top-gainers-losers-of-2-00-pm-08-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382108\" data-ts=\"1534182990\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FSAC\" target=\"_blank\">FSAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382108-federal-street-acquisition-to-combine-universal-hospital-services\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Federal Street Acquisition to combine with Universal Hospital Services</a></h4><ul>     <li>Federal Street Acquisition Corp. (<a href='https://seekingalpha.com/symbol/FSAC' title='Federal Street Acquisition Corp. Class A'>FSAC</a> <font color='green'>+2.8%</font>) and Universal Hospital Services have entered into a definitive merger agreement.</li>     <li>The combined company to be Named &ldquo;Agiliti, Inc.&rdquo; and Listed on Nasdaq Stock Market under the ticker symbols &ldquo;AGTI&rdquo;.</li>     <li>The purchase price implies an initial enterprise value for the combined company of ~$1.74B.</li><li><a href=\"https://seekingalpha.com/pr/17243046-federal-street-acquisition-corp-combine-universal-hospital-services\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3382108\" data-linked=\"Federal Street Acquisition to combine with Universal Hospital Services\" data-tweet=\"$FSAC - Federal Street Acquisition to combine with Universal Hospital Services https://seekingalpha.com/news/3382108-federal-street-acquisition-to-combine-universal-hospital-services?source=tweet\" data-url=\"https://seekingalpha.com/news/3382108-federal-street-acquisition-to-combine-universal-hospital-services\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:56 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382104\" data-ts=\"1534181626\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VSAT\" target=\"_blank\">VSAT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382104-viasat-rebounds-4_3-needham-looks-for-better-margins\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ViaSat rebounds 4.3% as Needham looks for better margins</a></h4><ul>   <li>Rebounding from a Friday <font color='red'>drop of 17%</font>, ViaSat (NASDAQ:<a href='https://seekingalpha.com/symbol/VSAT' title='Viasat, Inc.'>VSAT</a>) is <font color='green'>up 4.3%</font> amid a note from Needham looking for better margins and \"sharply ramping\" EBITDA.</li>    <li>Shares tumbled after the company posted a wider loss and what many saw as disappointing subscriber data.</li>    <li>\"The Consumer sub adds and outlook were disappointing, but we think can be mostly offset by higher ARPU,\" writes Needham's Richard Valera. He's Buy rated but has trimmed the price target to $70, from $74, now implying 12.7% upside. (h/t Bloomberg)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3381831-viasat-slides-17-percent-loss-sub-letdown\" target=\"_blank\">ViaSat slides 17% after loss, sub letdown</a> (Aug. 10 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3382104\" data-linked=\"ViaSat rebounds 4.3% as Needham looks for better margins\" data-tweet=\"$VSAT - ViaSat rebounds 4.3% as Needham looks for better margins https://seekingalpha.com/news/3382104-viasat-rebounds-4_3-needham-looks-for-better-margins?source=tweet\" data-url=\"https://seekingalpha.com/news/3382104-viasat-rebounds-4_3-needham-looks-for-better-margins\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:33 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382103\" data-ts=\"1534181342\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SIEB\" target=\"_blank\">SIEB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382103-siebert-financial-reports-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Siebert Financial reports Q2 results</a></h4><ul><li>Siebert Financial (NASDAQ:<a href='https://seekingalpha.com/symbol/SIEB' title='Siebert Financial Corp.'>SIEB</a>): Q2 EPS of $0.07</li><li>Revenue of $7.49M (+178.4% Y/Y)</li><li>Shares <font color='green'>+2%</font>.</li><li><a href='https://seekingalpha.com/pr/17243604-siebert-financial-corp-files-10q-reports-financial-results-second-quarter-2018'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3382103\" data-linked=\"Siebert Financial reports Q2 results\" data-tweet=\"$SIEB - Siebert Financial reports Q2 results https://seekingalpha.com/news/3382103-siebert-financial-reports-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3382103-siebert-financial-reports-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382102\" data-ts=\"1534180722\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALNY\" target=\"_blank\">ALNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382102-investors-not-enamored-alnylams-pricing-strategy-onpattro-shares-down-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Investors not enamored with Alnylam&#39;s pricing strategy with Onpattro; shares down 8%</a></h4><ul><li>The FDA approval of RNAi therapeutic ONPATTRO (patisiran) for hATT-stoked rally in Alnylam Pharmaceuticals (<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='red'>-8.2%</font>) is a memory. Shares jumped over<font color='green'> 3%</font>&nbsp;on the news but are down today on over four times normal volume.</li><li>Investors appear to lack confidence in its <a href=\"https://seekingalpha.com/pr/17242690-alnylam-announces-alignment-value-based-agreements-leading-health-insurers-launches\" target=\"_blank\">pricing approach.</a> List is $450K with a net of $345K for discounts and rebates. In addition, the company is negotiating value-based contracts with leading health insurers, already reaching agreement in principle with Harvard Pilgrim Health Care. These agreements feature tiered payments based on the ability of the medication to deliver the expected clinical outcomes. The better and more consistent the outcome, the higher the level of payment.</li><li><strong>Update</strong>: Another factor depressing shares could be the more narrow approval for patients with polyneuropathy, apparently excluding those with cardiomyopathy, due to hATTR. The <a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720049/\" target=\"_blank\">incidence </a>of the former is ~10K patients worldwide compared to ~40K for the latter.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382102\" data-linked=\"Investors not enamored with Alnylam&#39;s pricing strategy with Onpattro; shares down 8%\" data-tweet=\"$ALNY - Investors not enamored with Alnylam&#39;s pricing strategy with Onpattro; shares down 8% https://seekingalpha.com/news/3382102-investors-not-enamored-alnylams-pricing-strategy-onpattro-shares-down-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3382102-investors-not-enamored-alnylams-pricing-strategy-onpattro-shares-down-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382101\" data-ts=\"1534180493\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RUTH\" target=\"_blank\">RUTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382101-ruths-hospitality-heads-lower-after-raymond-james-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ruth&#39;s Hospitality heads lower after Raymond James downgrade</a></h4><ul> <li>Shares of Ruth's Hospitality Group (<a href='https://seekingalpha.com/symbol/RUTH' title='Ruth&#39;s Hospitality Group, Inc.'>RUTH</a> <font color='red'>-6.2%</font>) drop after Raymond James lowers its rating to Market Perform from Outperform.</li> <li>Analyst Brian Vaccaro says the chain's expected level of lower beef costs is already factored into guidance and Street consensus marks.</li> <li>Ruth's rose to a 52-week of $33.95 last week.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3382101\" data-linked=\"Ruth&#39;s Hospitality heads lower after Raymond James downgrade\" data-tweet=\"$RUTH - Ruth&#39;s Hospitality heads lower after Raymond James downgrade https://seekingalpha.com/news/3382101-ruths-hospitality-heads-lower-after-raymond-james-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3382101-ruths-hospitality-heads-lower-after-raymond-james-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382096\" data-ts=\"1534179638\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EHTH\" target=\"_blank\">EHTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382096-financials-top-gainers-losers-of-1-00-pm-08-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top Gainers / Losers as of 1:00 PM (08/13/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties'>IIPR</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/CLDC' title='China Lending Corporation'>CLDC</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SUPV' title='Grupo Supervielle'>SUPV</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/LX' title='LexinFintech Holdings Ltd. ADS'>LX</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/BMA' title='Banco Macro S.A.'>BMA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/YRD' title='Yirendai LTD.'>YRD</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/BFR' title='BBVA Banco Francs S.A.  ADR'>BFR</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382096\" data-linked=\"Financials - Top Gainers / Losers as of 1:00 PM (08/13/2018)\" data-tweet=\"$EHTH $EHTH $IIPR - Financials - Top Gainers / Losers as of 1:00 PM (08/13/2018) https://seekingalpha.com/news/3382096-financials-top-gainers-losers-of-1-00-pm-08-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3382096-financials-top-gainers-losers-of-1-00-pm-08-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382095\" data-ts=\"1534179424\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CHRA\" target=\"_blank\">CHRA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382095-charah-solutions-up-big-ahead-of-first-earnings-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Charah Solutions up big ahead of first earnings report</a></h4><ul><li>The provider of environmental and maintenance services to the coal and nuclear industries <a href=\"https://seekingalpha.com/news/3363827-charah-solutions-announces-pricing-initial-public-offering\" target=\"_blank\">came public in mid-June</a> at $12 per share and has mostly trended lower since.</li><li>It's set for its first public earnings report on Tuesday, and investors/shorts are buying ahead of the numbers. <a href='https://seekingalpha.com/symbol/CHRA' title='Charah Solutions'>CHRA</a>&nbsp;<font color='green'>+18.5%</font>&nbsp;to $7.89.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382095\" data-linked=\"Charah Solutions up big ahead of first earnings report\" data-tweet=\"$CHRA - Charah Solutions up big ahead of first earnings report https://seekingalpha.com/news/3382095-charah-solutions-up-big-ahead-of-first-earnings-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3382095-charah-solutions-up-big-ahead-of-first-earnings-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382094\" data-ts=\"1534179184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABIL\" target=\"_blank\">ABIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382094-midday-gainers-losers-08-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (08/13/2018)</a></h4><ul>     <li><strong>Gainers:</strong> <a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+50%</font>. <a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/TKAT' title='Takung Art Co., Ltd.'>TKAT</a> <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/CHRA' title='Charah Solutions'>CHRA</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf'>DBD</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/MTEX' title='Mannatech, Incorporated'>MTEX</a> <font color='green'>+13%</font>. ITUS <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/ATRS' title='Antares Pharma Inc.'>ATRS</a> <font color='green'>+11%</font>.</li>     <li><strong>Losers:&nbsp;</strong><a href='https://seekingalpha.com/symbol/DY' title='Dycom Industries Inc.'>DY</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/BEDU' title='Bright Scholar Education'>BEDU</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/DTRM' title='Determine, Inc.'>OTC:DTRM</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/SYN' title='Synthetic Biologics, Inc.'>SYN</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/HLG' title='Hailiang Education Group Inc.'>HLG</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/CBLI' title='Cleveland BioLabs, Inc.'>CBLI</a> <font color='red'>-14%</font>.</li>      &nbsp; </ul><div class=\"tiny-share-widget\" data-id=\"3382094\" data-linked=\"Midday Gainers / Losers (08/13/2018)\" data-tweet=\"$ABIL $ABIL $IDRA - Midday Gainers / Losers (08/13/2018) https://seekingalpha.com/news/3382094-midday-gainers-losers-08-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3382094-midday-gainers-losers-08-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:53 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382092\" data-ts=\"1534179050\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DBD\" target=\"_blank\">DBD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382092-cnbc-diebold-nixdorf-hires-advisers-for-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CNBC: Diebold Nixdorf hires advisers for sale</a></h4><ul><li>        Diebold Nixdorf (NYSE:<a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf'>DBD</a>) has hired Credit Suisse and Evercore to seek a potential sale, according to <a href=\"https://www.cnbc.com/2018/08/13/diebold-nixdorf-hires-advisers-to-seek-a-sale-sources-say.html\" target=\"_blank\">CNBC sources</a>.</li><li>               The advisers will help identify potential buyers with a focus on private-equity firms and NCR.&nbsp;</li><li>               Diebold recently forecasted lower-than-expected EBITDA and revealed it would use cash on hand and its revolving credit line to acquire $160M in Wincor Nixdorf shares.&nbsp;</li><li>               Diebold bought Wincor in 2016 but not all of the shareholders tendered the offer. At the end of July, Diebold only held 77% of outstanding shares.&nbsp;</li><li>                  Diebold shares are&nbsp;<font color='green'>up 16.7%</font>&nbsp;to $4.55.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3381963-diebold-nixdorf-plus-8_9-percent-lender-monetization-updates\" target=\"_blank\">Diebold Nixdorf +8.9% on lender, monetization updates</a> (Aug. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3382092\" data-linked=\"CNBC: Diebold Nixdorf hires advisers for sale\" data-tweet=\"$DBD - CNBC: Diebold Nixdorf hires advisers for sale https://seekingalpha.com/news/3382092-cnbc-diebold-nixdorf-hires-advisers-for-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3382092-cnbc-diebold-nixdorf-hires-advisers-for-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382091\" data-ts=\"1534178729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYY\" target=\"_blank\">SYY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382091-syscoplus-7-post-q4-earnings-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sysco +7% post Q4 earnings beat</a></h4><ul>     <li>Sysco (<a href='https://seekingalpha.com/symbol/SYY' title='Sysco Corporation'>SYY</a> <font color='green'>+7.2%</font>) rose by 7% after its Q4 earnings edges past estimates.</li>     <li>Q4 sales of $15.3B (+6.2% Y/Y); gross profit of $2.9B (+5.7%); operating income of $687.7M (+23.2%) and adj. operating income of $771.2M (+15.7%).</li><li>FY18 sales of $58.7B (+6.1%); gross profit of $11.1B (+5%); operating income of $2.3B (13.4%) and adj. operating income of $2.5B (+8.4%).</li>     <li>CEO Tom Ben&eacute;; \"..As we head into fiscal 2019, we remain confident in our ability to profitably grow the business and accomplish our objectives&rdquo;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3381940-sysco-beats-0_01-beats-revenue\" target=\"_blank\">Sysco beats by $0.01, beats on revenue</a> (Aug. 13)</li><li><a href=\"https://seekingalpha.com/pr/17243094-sysco-reports-fourth-quarter-full-year-2018-earnings\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3382091\" data-linked=\"Sysco +7% post Q4 earnings beat\" data-tweet=\"$SYY - Sysco +7% post Q4 earnings beat https://seekingalpha.com/news/3382091-syscoplus-7-post-q4-earnings-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3382091-syscoplus-7-post-q4-earnings-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382086\" data-ts=\"1534178042\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WLMIF\" target=\"_blank\">WLMIF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382086-on-wilmar-internationals-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Wilmar International&#39;s Q2 results</a></h4><ul><li>Wilmar International (<a href='https://seekingalpha.com/symbol/WLMIF' title='Wilmar International, Ltd.'>OTCPK:WLMIF</a>) reported Q2 revenue growth of 1.9% Y/Y to $10.8B and a tenfold increase in the core net profit to $351.8M (+875% Y/Y). The increase was attributed to strong performance from the Oilseeds &amp; Grains and Tropical Oils segments.</li><li>Tropical oils segment: Revenue $4.17B (-4% Y/Y); Sales volumes 5.6M metric tons (-3.5% Y/Y), production yield for plantation 5.8 metric tons (+11% Y/Y), production of fresh fruits bunches 1,081,425 MT (+5% Y/Y). The pretax profit was $154.9M (+165% Y/Y).</li><li>Oil seeds &amp; grains segment: Revenue $5.3B (+22% Y/Y); Sales volumes 7.5M MT (+12% Y/) with consumer products t 1.2M MT (+7% Y/Y). Pretax profit of $290.2M (+381% Y/Y).</li><li>Sugar segment: Revenue $1.2B (-36% Y/Y); Sales volumes 2.8M MT (-11% Y/Y) and pretax loss of $46.2M compared to $106.8M a year ago.</li><li>Q2 EBITDA increased by 118% Y/Y to $699.5M and margin<font color='green'> improved by 345 bps</font>&nbsp;to 6.5%.</li><li>Net cash flow generated from operating activities $787M compared to $396M a year ago and FCF of $79M compared to $282M a year ago.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3381878-wilmar-international-reports-q2-results\" target=\"_blank\">Wilmar International reports Q2 results</a> (Aug. 13)</li><li><a href=\"http://media.corporate-ir.net/media_files/IROL/16/164878/Wilmar-2Q2018-Financial-Results-Highlights-Presentation.pdf\" target=\"_blank\">Presentation</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3382086\" data-linked=\"More on Wilmar International&#39;s Q2 results\" data-tweet=\"$WLMIF $WLMIY - More on Wilmar International&#39;s Q2 results https://seekingalpha.com/news/3382086-on-wilmar-internationals-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3382086-on-wilmar-internationals-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382084\" data-ts=\"1534177582\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ENDP\" target=\"_blank\">ENDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382084-endo-under-modest-pressure-on-athenex-vasopressin-launch-shares-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Endo under modest pressure on Athenex vasopressin launch, shares down 3%</a></h4><ul><li>Endo International (<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a> <font color='red'>-3.3%</font>) slips on below-average volume in apparent reaction to the Athenex's U.S. launch of its generic vasopressin, a diuretic that is Endo's top seller, accounting for almost 15% of its Q2 sales ($106.3/$714.7).</li><li>Legal action is likely since Endo says compounding of vasopressin should not be allowed.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3382027-athenex-launches-vasopressin-ready-use-premix-iv-bags-u-s\" target=\"_blank\">Athenex launches vasopressin ready-to-use premix IV bags in U.S.</a> (Aug. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3382084\" data-linked=\"Endo under modest pressure on Athenex vasopressin launch, shares down 3%\" data-tweet=\"$ENDP - Endo under modest pressure on Athenex vasopressin launch, shares down 3% https://seekingalpha.com/news/3382084-endo-under-modest-pressure-on-athenex-vasopressin-launch-shares-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3382084-endo-under-modest-pressure-on-athenex-vasopressin-launch-shares-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:26 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382079\" data-ts=\"1534176890\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SYN\" target=\"_blank\">SYN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382079-synthetic-bio-continues-slide-down-15\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synthetic Bio continues slide, down 15%</a></h4><ul><li>Nano cap Synthetic Biologics (<a href='https://seekingalpha.com/symbol/SYN' title='Synthetic Biologics, Inc.'>SYN</a> <font color='red'>-14.8%</font>) is down on below-average volume. Shares have lost almost&nbsp;<font color='red'>65%</font>&nbsp;of their value since <a href=\"https://seekingalpha.com/pr/17233575-synthetic-biologics-announces-reverse-stock-split\" target=\"_blank\">announcing</a> a 1:35 reverse split of its common stock on August 1. Post-split trading started today.</li><li>Last week, it released its Q2 report. Cash and equivalents totaled $7.1M at quarter-end while operations consumed $10.4M in H1.</li><li>On <a href=\"https://www.sec.gov/Archives/edgar/data/894158/000114420418042887/tv499157_10q.htm#a_003\" target=\"_blank\">page 8</a> of its 10-Q the company states that it does not have sufficient capital to fund operations for the next 12 months.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382079\" data-linked=\"Synthetic Bio continues slide, down 15%\" data-tweet=\"$SYN - Synthetic Bio continues slide, down 15% https://seekingalpha.com/news/3382079-synthetic-bio-continues-slide-down-15?source=tweet\" data-url=\"https://seekingalpha.com/news/3382079-synthetic-bio-continues-slide-down-15\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382078\" data-ts=\"1534176708\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DTRM\" target=\"_blank\">DTRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382078-needham-lowers-determine-target-dtrmminus-17_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Needham lowers Determine target; DTRM -17.6%</a></h4><ul><li>        Needham <a href=\"https://www.streetinsider.com/Analyst+Comments/Determine+%28DTRM%29+PT+Lowered+to+%243+at+Needham+%26+Company/14503510.html\" target=\"_blank\">lowers</a> its Determine (<a href='https://seekingalpha.com/symbol/DTRM' title='Determine, Inc.'>OTC:DTRM</a>) price target by $4 to $3 compared to Friday&rsquo;s closing price of $1.19.</li><li>               Rating maintained at Buy.&nbsp;</li><li>               Analyst Scott Berg cites Q1 results that came in below the firm&rsquo;s estimates as the timing of several deals were pushed into Q2.&nbsp;</li><li>               Berg likes the new sales changes but takes a conservative stance as to when that can positively impact deal flow.&nbsp;</li><li>               Determine shares are<font color='red'> down 17.6%</font>&nbsp;to $0.98. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3366369-determine-misses-0_02-misses-revenue\" target=\"_blank\">Determine misses by $0.02, misses on revenue</a> (June 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3382078\" data-linked=\"Needham lowers Determine target; DTRM -17.6%\" data-tweet=\"$DTRM - Needham lowers Determine target; DTRM -17.6% https://seekingalpha.com/news/3382078-needham-lowers-determine-target-dtrmminus-17_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3382078-needham-lowers-determine-target-dtrmminus-17_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382077\" data-ts=\"1534176664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382077-quick-plunge-in-oil-hits-averages\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quick plunge in oil hits averages</a></h4><ul><li>As usual, U.S. equity markets had mostly been ignoring declines - some rather large - across the globe today. But the price of oil (NYSEARCA:<a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>) has&nbsp;<font color='red'>sunk 2%</font>&nbsp;in the last few minutes, taking the energy sector (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='red'>-0.7%</font>) with it. That's brought the Dow and S&amp;P 500 modestly into the red, and the Nasdaq back to flat.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>, <a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a>, <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a>, <a href='https://seekingalpha.com/symbol/UWT' title='VelocityShares 3X Long Crude ETN'>UWT</a>, <a href='https://seekingalpha.com/symbol/UCO' title='ProShares Ultra Bloomberg Crude Oil ETF'>UCO</a>, <a href='https://seekingalpha.com/symbol/VDE' title='Vanguard Energy ETF'>VDE</a>, <a href='https://seekingalpha.com/symbol/DWT' title='VelocityShares 3x Inverse Crude Oil ETN'>DWT</a>, <a href='https://seekingalpha.com/symbol/ERX' title='Direxion Daily Energy Bull 3x Shares ETF'>ERX</a>, <a href='https://seekingalpha.com/symbol/OIH' title='VanEck Vectors Oil Services ETF'>OIH</a>, <a href='https://seekingalpha.com/symbol/SCO' title='ProShares UltraShort Bloomberg Crude Oil ETF'>SCO</a>, <a href='https://seekingalpha.com/symbol/BNO' title='The United States Brent Oil ETF, LP'>BNO</a>, <a href='https://seekingalpha.com/symbol/DBO' title='Invesco DB Oil ETF'>DBO</a>, <a href='https://seekingalpha.com/symbol/ERY' title='Direxion Daily Energy Bear 3x Shares ETF'>ERY</a>, <a href='https://seekingalpha.com/symbol/DIG' title='ProShares Ultra Oil & Gas ETF'>DIG</a>, <a href='https://seekingalpha.com/symbol/UGA' title='The United States Gasoline ETF, LP'>UGA</a>, <a href='https://seekingalpha.com/symbol/BGR' title='BlackRock Energy&Resources Trust'>BGR</a>, <a href='https://seekingalpha.com/symbol/DTO' title='DB Crude Oil Double Short ETN'>DTO</a>, <a href='https://seekingalpha.com/symbol/FENY' title='Fidelity MSCI Energy Index ETF'>FENY</a>, <a href='https://seekingalpha.com/symbol/USL' title='The United States 12 Month Oil ETF, LP'>USL</a>, <a href='https://seekingalpha.com/symbol/IYE' title='iShares U.S. Energy ETF'>IYE</a>, <a href='https://seekingalpha.com/symbol/DUG' title='ProShares UltraShort Oil & Gas ETF'>DUG</a>, <a href='https://seekingalpha.com/symbol/FIF' title='First Trust Energy Infrastructure Fund'>FIF</a>, <a href='https://seekingalpha.com/symbol/DNO' title='The United States Short Oil ETF, LP'>DNO</a>, <a href='https://seekingalpha.com/symbol/OLO' title='DB Crude Oil Long ETN'>OLO</a>, <a href='https://seekingalpha.com/symbol/RYE' title='Invesco S&P Equal Weight Energy ETF'>RYE</a>, <a href='https://seekingalpha.com/symbol/PXJ' title='Invesco Dynamic Oil & Gas Services Portfolio ETF'>PXJ</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3382077\" data-linked=\"Quick plunge in oil hits averages\" data-tweet=\"$USO $XLE $OIL - Quick plunge in oil hits averages https://seekingalpha.com/news/3382077-quick-plunge-in-oil-hits-averages?source=tweet\" data-url=\"https://seekingalpha.com/news/3382077-quick-plunge-in-oil-hits-averages\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>33&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382076\" data-ts=\"1534176278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELF\" target=\"_blank\">ELF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382076-comeback-bounce-for-e-l-f-beauty\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comeback bounce for e.l.f. Beauty</a></h4><ul> <li>Investors have bid up e.l.f. Beauty (NYSE:<a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a>)&nbsp;<font color='green'>by 10.31%</font>&nbsp;after last week's sharp beauty sector downturn is seen by some traders as overdone.</li> <li>Shares of ELF dipped below $10 last week for the first time ever to push the forward PE multiple on the stock back below 20.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3380893-post-ipo-low-e-l-f-beauty-sales-growth-slows\" target=\"_blank\">Post-IPO low for e.l.f. Beauty after sales growth slows</a> (Aug. 9)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3382076\" data-linked=\"Comeback bounce for e.l.f. Beauty\" data-tweet=\"$ELF - Comeback bounce for e.l.f. Beauty https://seekingalpha.com/news/3382076-comeback-bounce-for-e-l-f-beauty?source=tweet\" data-url=\"https://seekingalpha.com/news/3382076-comeback-bounce-for-e-l-f-beauty\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382072\" data-ts=\"1534176036\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTEX\" target=\"_blank\">MTEX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382072-consumer-top-gainers-losers-of-12-00-pm-08-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 PM (08/13/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MTEX' title='Mannatech, Incorporated'>MTEX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/FOSL' title='Fossil, Inc.'>FOSL</a> <font color='green'>+5%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/LFVN' title='LifeVantage Corporation'>LFVN</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/SONO' title='Sonos, Inc.'>SONO</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='red'>-8%</font>. AOI <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382072\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 PM (08/13/2018)\" data-tweet=\"$MTEX $MTEX $ELF - Consumer - Top Gainers / Losers as of 12:00 PM (08/13/2018) https://seekingalpha.com/news/3382072-consumer-top-gainers-losers-of-12-00-pm-08-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3382072-consumer-top-gainers-losers-of-12-00-pm-08-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382071\" data-ts=\"1534175979\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAYRY\" target=\"_blank\">BAYRY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382071-bayer-drops-to-five-year-low-on-roundup-verdict-sinks-scotts-miracle-gro\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bayer drops to five-year low on Roundup verdict, sinks Scotts Miracle-Gro</a></h4><ul>     <li>Bayer (<a href='https://seekingalpha.com/symbol/BAYRY' title='Bayer A.G. ADR'>OTCPK:BAYRY</a> <font color='red'>-10.4%</font>) plunges as much as 14% to a five-year low in the wake of a California's jury award of $289M to a man with terminal cancer, which could be <a href=\"https://www.reuters.com/article/us-monsanto-cancer-lawsuit-bayer/roundup-cancer-verdict-sends-bayer-shares-sliding-idUSKBN1KY0M5\" target=\"_blank\">the first of potentially thousands of U.S. lawsuits</a> alleging the company failed to warn of the cancer risks of glyphosate-based weedkillers including its Roundup brand.</li>     <li>&ldquo;While an appeal is certain and may indeed likely result in the penalty being moderated at a minimum if not reversed altogether, a large number of similar pending cases will now likely multiply,&rdquo; Barclays analysts write, warning of a \"litigious headache\" for Bayer.</li>     <li>Berenberg's Alistair Campbell says resolving the issue could cost Bayer $5B, citing a rough estimate based on a past product liability settlements such as Merck&rsquo;s $4.9B settlement over the Vioxx painkiller or Bayer&rsquo;s $4.2B total settlement over the Baycol cholesterol drug.</li>     <li>But J.P. Morgan's Richard Vosser reiterates Bayer as an Outperform, viewing today's selloff as \"significantly overdone\" with the potential for the verdict to be overturned on appeal and for the damage amount to be greatly reduced.</li>     <li>Meanwhile, BofA Merrill Lynch's Christopher Carey  notes that while the product is owned by Monsanto, Scotts Miracle-Gro (<a href='https://seekingalpha.com/symbol/SMG' title='The Scotts Miracle-Gro Company'>SMG</a> <font color='red'>-3.1%</font>) is the exclusive distributor and marketer of consumer Roundup in the U.S. and Canada, and the court decision \"<a href=\"https://thefly.com/thestreet/realmoney/index.php/SMGid2776400/SMG-Roundup-ruling-adds-cloud-over-important-product-for-Scotts-MiracleGro-says-BofAMerrill\" target=\"_blank\">adds a cloud</a>\" over a product which is important for the company; he reiterates an Underperform rating and $74 price target on SMG shares.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382071\" data-linked=\"Bayer drops to five-year low on Roundup verdict, sinks Scotts Miracle-Gro\" data-tweet=\"$BAYRY $BAYRY $SMG - Bayer drops to five-year low on Roundup verdict, sinks Scotts Miracle-Gro https://seekingalpha.com/news/3382071-bayer-drops-to-five-year-low-on-roundup-verdict-sinks-scotts-miracle-gro?source=tweet\" data-url=\"https://seekingalpha.com/news/3382071-bayer-drops-to-five-year-low-on-roundup-verdict-sinks-scotts-miracle-gro\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>73&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382069\" data-ts=\"1534175630\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AVID\" target=\"_blank\">AVID</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382069-avid-tech-director-acquires-shares-avidplus-7_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Avid Tech director acquires shares; AVID +7.6%</a></h4><ul><li>        Avid Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/AVID' title='Avid Technology, Inc.'>AVID</a>) chairman Peter Westley <a href=\"https://seekingalpha.com/filing/4134625\" target=\"_blank\">acquired</a> 15,782 shares, according to a filing on Friday.</li><li>               The acquisition represented an award of restricted stock units that will vest in full on May 8, the date of the company&rsquo;s annual meeting.&nbsp;</li><li>               Avid Tech shares are&nbsp;<font color='green'>up 7.6%</font>&nbsp;to $5.96.&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3381276-avid-eps-0_20\" target=\"_blank\">Avid EPS of -$0.20</a> (Aug. 9)</li><li>&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3382069\" data-linked=\"Avid Tech director acquires shares; AVID +7.6%\" data-tweet=\"$AVID - Avid Tech director acquires shares; AVID +7.6% https://seekingalpha.com/news/3382069-avid-tech-director-acquires-shares-avidplus-7_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3382069-avid-tech-director-acquires-shares-avidplus-7_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:53 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382064\" data-ts=\"1534174915\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WOW\" target=\"_blank\">WOW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382064-wideopenwestminus-4_4-evercore-cuts-to-in-line\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">WideOpenWest -4.4% as Evercore cuts to In-line</a></h4><ul>   <li>WideOpenWest (NYSE:<a href='https://seekingalpha.com/symbol/WOW' title='WideOpenWest, Inc.'>WOW</a>) is <font color='red'>4.4% lower</font> today after a downgrade by Evercore ISI, to In-line.</li>    <li>Shares are fairly valued after nearly doubling since May, a move brought on by short-term buybacks and purchases by Crestview, analyst James Ratcliffe says. And that valuation is still below <a href=\"https://seekingalpha.com/news/3269904-wideopenwest-debuts-16-ipo-price\" target=\"_blank\">last year's IPO price</a>.</li>    <li>He's seen encouraging operating results from Q2 and raising his price target to $14 from $13, now implying 15.5% upside. (h/t Bloomberg)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3382064\" data-linked=\"WideOpenWest -4.4% as Evercore cuts to In-line\" data-tweet=\"$WOW - WideOpenWest -4.4% as Evercore cuts to In-line https://seekingalpha.com/news/3382064-wideopenwestminus-4_4-evercore-cuts-to-in-line?source=tweet\" data-url=\"https://seekingalpha.com/news/3382064-wideopenwestminus-4_4-evercore-cuts-to-in-line\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382062\" data-ts=\"1534174559\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPI\" target=\"_blank\">EXPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382062-exp-world-holdings-down-2_9-despite-strong-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">eXp World Holdings down 2.9% despite strong Q2 results</a></h4><ul><li>eXp World Holdings (<a href='https://seekingalpha.com/symbol/EXPI' title='eXp World Holdings, Inc.'>EXPI</a> <font color='red'>-2.9%</font>)&nbsp;<a href=\"https://seekingalpha.com/pr/17243334-exp-world-holdings-reports-record-second-quarter-2018-results\" target=\"_blank\">reports Q2</a>&nbsp;revenue growth of 234.9% Y/Y to $130.5M.</li><li>Gross margin&nbsp;<font color='red'>declined 127 bps</font>&nbsp;to 9.5%.</li><li>Adj. EBITDA significantly increased to $3.4M.</li><li>Cash flow from operations was $8.6M (+1620% Y/Y).</li><li>Residential transaction sides closed was 19,903 (+214% Y/Y).</li><li>Residential transaction volume closed was $5.3B (+251% Y/Y).</li><li>Agent count was 11,856 (+203%Y/Y).</li><li>&ldquo;We received a number of industry honors this quarter due to our amazing agents as they continue to deliver top production numbers, including this quarter&rsquo;s record transaction and volume levels,&rdquo; said eXp World Holdings CEO, Chairman and Founder&nbsp;Glenn Sanford.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3381991-exp-world-beats-0_09-beats-revenue\" target=\"_blank\">eXp World beats by $0.09, beats on revenue</a> (Aug. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3382062\" data-linked=\"eXp World Holdings down 2.9% despite strong Q2 results\" data-tweet=\"$EXPI - eXp World Holdings down 2.9% despite strong Q2 results https://seekingalpha.com/news/3382062-exp-world-holdings-down-2_9-despite-strong-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3382062-exp-world-holdings-down-2_9-despite-strong-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382063\" data-ts=\"1534174503\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KEYS\" target=\"_blank\">KEYS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382063-keysight-technologies-acquires-calibration-facility-company\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Keysight Technologies acquires calibration facility company</a></h4><ul><li>        Keysight Technologies (NYSE:<a href='https://seekingalpha.com/symbol/KEYS' title='Keysight Technologies Inc.'>KEYS</a>) <a href=\"https://seekingalpha.com/pr/17243490-keysight-technologies-acquires-thales-calibration-services\" target=\"_blank\">acquires</a> Thales Calibration Services for an undisclosed amount.</li><li>               Thales Calibration, a subsidiary of Thales Group, provides commercial calibration facilities specializing in dimensional, pressure, mass, and temperature meteorology for a variety of industries including defense and pharmaceuticals.&nbsp;</li><li>               The acquisition was effective as of July&nbsp;</li><li>               Keysight shares are&nbsp;<font color='green'>up 0.6%</font>&nbsp;to $60.28.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3382063\" data-linked=\"Keysight Technologies acquires calibration facility company\" data-tweet=\"$KEYS - Keysight Technologies acquires calibration facility company https://seekingalpha.com/news/3382063-keysight-technologies-acquires-calibration-facility-company?source=tweet\" data-url=\"https://seekingalpha.com/news/3382063-keysight-technologies-acquires-calibration-facility-company\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382057\" data-ts=\"1534173918\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AG\" target=\"_blank\">AG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382057-first-majestic-silverminus-12-after-larger-expected-q2-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">First Majestic Silver -12% after larger than expected Q2 loss</a></h4><ul>     <li>First Majestic Silver (<a href='https://seekingalpha.com/symbol/AG' title='First Majestic Silver Corp.'>AG</a> <font color='red'>-12.2%</font>) slumps after reporting a wider than expected <a href=\"https://seekingalpha.com/news/3381900-first-majestic-silver-reports-q2-results\" target=\"_blank\">Q2 loss</a> despite record silver equivalent production, which was <a href=\"https://seekingalpha.com/news/3370500-first-majestic-reports-record-q2-silver-equiv-production-raises-guidance\" target=\"_blank\">previously reported</a>.</li>     <li>AG says Q2 revenue rose by a third from the prior-year quarter, helped by a 43% jump in silver equiv. oz. sold to 5.1M and a 3% rise in the average realized silver price to $16.74/oz.</li>     <li>AG&nbsp;says total production for July reached a <a href=\"http://www.kitco.com/news/2018-08-13/First-Majestic-Silver-Posts-Loss-In-Second-Quarter.html\" target=\"_blank\">new monthly record</a> of 2.2M silver equiv. oz., a trend it expects to continue throughout the rest of 2018 and into H1 2019.</li>     <li>But all-in sustaining costs climbed 16% Y/Y and 3% Q/Q to $16.43/oz., as AG cited higher G&amp;A expenses and sustaining capex tied to the Primero Mining acquisition, the integration of the San Dimas mine into its portfolio, and lower production from La&nbsp;Encantada and Del Toro.</li>     <li>AG says AISC should decrease in H2 to $13.28-$14.84 due to expected operational improvements at La Encantada, Del Toro and San Dimas; already, AISC at San Dimas was  $5.41/oz., making it the company's lowest cost and largest producing mine.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3382057\" data-linked=\"First Majestic Silver -12% after larger than expected Q2 loss\" data-tweet=\"$AG - First Majestic Silver -12% after larger than expected Q2 loss https://seekingalpha.com/news/3382057-first-majestic-silverminus-12-after-larger-expected-q2-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3382057-first-majestic-silverminus-12-after-larger-expected-q2-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382055\" data-ts=\"1534173707\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MYL\" target=\"_blank\">MYL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382055-mylan-launches-generic-adcirca-in-u-s-shares-up-1\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mylan launches generic Adcirca in U.S.; shares up 1%</a></h4><ul><li>Mylan N.V. (<a href='https://seekingalpha.com/symbol/MYL' title='Mylan Inc'>MYL</a> <font color='green'>+1%</font>) <a href=\"https://seekingalpha.com/pr/17243488-mylan-launches-first-generic-adcirca-tablets\" target=\"_blank\">commences </a>the U.S. commercial launch of its generic version of Eli Lilly's (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color='green'>+0.1%</font>) Adcirca (tadalafil) for patients with pulmonary arterial hypertension.</li><li>Per IQVIA, the U.S. market is ~$510M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382055\" data-linked=\"Mylan launches generic Adcirca in U.S.; shares up 1%\" data-tweet=\"$MYL $MYL $LLY - Mylan launches generic Adcirca in U.S.; shares up 1% https://seekingalpha.com/news/3382055-mylan-launches-generic-adcirca-in-u-s-shares-up-1?source=tweet\" data-url=\"https://seekingalpha.com/news/3382055-mylan-launches-generic-adcirca-in-u-s-shares-up-1\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382052\" data-ts=\"1534172750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAO\" target=\"_blank\">AKAO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382052-achaogen-continues-slide-down-9\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Achaogen continues slide, down 9%</a></h4><ul><li>Achaogen (<a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a> <font color='red'>-9.2%</font>) is down on modestly higher volume. Shares have lost almost 60% of their value since touching $13.48 on June 21, the day after launching ZEMDRI (plazomicin) for the treatment of adults with complicated urinary tract infections and five days before announcing a restructuring.</li><li>At the end of June, it had $100.5M in quick assets. Operations consumed $89.1M in H1.</li><li>On <a href=\"https://www.sec.gov/Archives/edgar/data/1301501/000156459018019496/akao-10q_20180630.htm#CONDENSED_CONSOLIDATED_BALANCE_SHEETS\" target=\"_blank\">page 32</a> of its Q2 report, the company says it plans to raise additional capital, equity or debt or other, to support the commercialization of ZEMDRI and its ongoing R&amp;D activities.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3374602-achaogen-restructures-shakes-management\" target=\"_blank\">Achaogen restructures, shakes up management</a> (July 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3382052\" data-linked=\"Achaogen continues slide, down 9%\" data-tweet=\"$AKAO - Achaogen continues slide, down 9% https://seekingalpha.com/news/3382052-achaogen-continues-slide-down-9?source=tweet\" data-url=\"https://seekingalpha.com/news/3382052-achaogen-continues-slide-down-9\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382050\" data-ts=\"1534172693\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TWTR\" target=\"_blank\">TWTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382050-twitterplus-4_3-amid-new-bullishness-citron\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Twitter +4.3% amid new bullishness at Citron</a></h4><ul>   <li>Twitter (NYSE:<a href='https://seekingalpha.com/symbol/TWTR' title='Twitter, Inc.'>TWTR</a>) is <font color='green'>up 4.3%</font> to two-week highs after another bullish note from Citron Research, which has whipsawed positions a few times this year.</li>    <li>The social media firm \"has hit a <a href=\"https://twitter.com/CitronResearch/status/1029013938787180544\" target=\"_blank\">level of relevancy</a> as never before. With privacy concerns in its rear view &amp; execution on all fronts -- Citron expects new highs,\" the firm tweets to promote a new report.</li>    <li>Those privacy concerns led Citron to produce a <a href=\"https://seekingalpha.com/news/3341902-twitter-minus-4_6-percent-citron-shorts-data-privacy-vulnerability\" target=\"_blank\">short note in March</a>, saying \"Wait until the Senate hears Twitter's hidden secret.\" Twitter was most vulnerable to privacy regulation among the social media firms, Citron said.</li>    <li>That followed a <a href=\"https://seekingalpha.com/news/3329474-citrons-left-sells-twitter-stake-amid-run\" target=\"_blank\">sell-off of a long position</a> in February after <a href=\"https://seekingalpha.com/news/3325826-citron-twitter-train-amid-deal-chatter-shares-9_3-percent\" target=\"_blank\">going long</a> on speculation of a buyout from the likes of Tencent.</li>    <li>Andrew Left's firm now has a one-year price target of $52, implying 55% upside.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3382050\" data-linked=\"Twitter +4.3% amid new bullishness at Citron\" data-tweet=\"$TWTR - Twitter +4.3% amid new bullishness at Citron https://seekingalpha.com/news/3382050-twitterplus-4_3-amid-new-bullishness-citron?source=tweet\" data-url=\"https://seekingalpha.com/news/3382050-twitterplus-4_3-amid-new-bullishness-citron\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382049\" data-ts=\"1534172687\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMD\" target=\"_blank\">AMD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382049-amdplus-4_1-on-2990wx-launch-positive-reviews-against-intel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AMD +4.1% on 2990WX launch, positive reviews against Intel</a></h4><ul><li>        AMD (NASDAQ:<a href='https://seekingalpha.com/symbol/AMD' title='Advanced Micro Devices, Inc.'>AMD</a>) <a href=\"https://seekingalpha.com/pr/17243341-amd-launches-world-s-powerful-desktop-processor-bigger-better-2nd-generation-amd-ryzen\" target=\"_blank\">releases</a> the 32-core, 64-thread second-generation Ryzen Threadripper 2990WX for $1,799.</li><li>               Other specs: 4.2GHz boost/3.0GHz base, 64MB L3 cache, 250W TDP, 64 PCLe Gen 3.0 lanes.&nbsp;</li><li>               AMD says the 2990WX delivers up to 53% faster multi-thread performance than Intel&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/INTC' title='Intel Corporation'>INTC</a>) Core i9-7980XE and offers up to 47% more rendering performance&nbsp;</li><li>               Next Threadripper releases: The 2950X, which Gizmodo <a href=\"https://gizmodo.com/amds-16-core-beast-quickly-creams-intels-but-you-might-1828292147\" target=\"_blank\">says</a> &ldquo;creams&rdquo; Intel, will launch on August 31. Customers can expect the $1,299 2970WX and the $649 2920X in October.&nbsp;</li><li>               AMD shares are&nbsp;<font color='green'>up 4.1%</font>&nbsp;to $19.85 and Intel is&nbsp;<font color='green'>up 0.6%</font>&nbsp;to $49.12.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3381605-amd-plus-1_4-percent-goldman-upgrade-intel-competition-update\" target=\"_blank\">AMD +1.4% on Goldman upgrade for Intel competition (update)</a> (Aug. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3382049\" data-linked=\"AMD +4.1% on 2990WX launch, positive reviews against Intel\" data-tweet=\"$AMD $AMD $INTC - AMD +4.1% on 2990WX launch, positive reviews against Intel https://seekingalpha.com/news/3382049-amdplus-4_1-on-2990wx-launch-positive-reviews-against-intel?source=tweet\" data-url=\"https://seekingalpha.com/news/3382049-amdplus-4_1-on-2990wx-launch-positive-reviews-against-intel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>556&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382047\" data-ts=\"1534172452\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIO\" target=\"_blank\">XBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382047-healthcare-top-5-gainers-losers-of-11-00-08-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 AM (08/13/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/IDRA' title='Idera Pharmaceuticals, Inc.'>IDRA</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/VNRX' title='VolitionRX Ltd'>VNRX</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/OPNT' title='Opiant Pharmaceuticals, Inc.'>OPNT</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/CASI' title='CASI Pharmaceuticals'>CASI</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AKAO' title='Achaogen'>AKAO</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a> <font color='red'>-12%</font>. <a href='https://seekingalpha.com/symbol/SNOA' title='Sonoma Pharmaceuticals, Inc.'>SNOA</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/SYN' title='Synthetic Biologics, Inc.'>SYN</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382047\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 AM (08/13/2018)\" data-tweet=\"$XBIO $XBIO $IDRA - Healthcare - Top 5 Gainers / Losers as of 11:00 AM (08/13/2018) https://seekingalpha.com/news/3382047-healthcare-top-5-gainers-losers-of-11-00-08-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3382047-healthcare-top-5-gainers-losers-of-11-00-08-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382042\" data-ts=\"1534171764\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSC-OLD\" target=\"_blank\">SSC-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382042-seven-stars-cloudminus-6_5-after-spending-widens-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Seven Stars Cloud -6.5% after spending widens loss</a></h4><ul>   <li>Seven Stars Cloud (NASDAQ:<a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>) is <font color='red'>off 6.5%</font>, reversing some early premarket gains, after posting <a href=\"https://seekingalpha.com/news/3381914-seven-stars-cloud-reports-q2-results\" target=\"_blank\">Q2 earnings</a> where revenues tripled but net losses more than doubled with the company focused on growth engines.</li>    <li>Gross profit jumped to $1.5M from $55,145, but the company significantly higher SG&amp;A expense (mainly from share-based compensation to draw talent) along with new spending on research and development that raised operating expenses 160%.</li>    <li>\"SSC will begin to realize the full potential of the assets and partnerships that will drive the Company's four key product engines &ndash; all with operations and actual clients due to go live in 2018,\" says CEO/Chairman Bruno Wu. \"We fully expect these assets and partnerships to help generate significant shareholder value over the long term.\"</li>    <li>Year-to-date revenue is pacing at a multiple of four, up 317% to $319M.</li>    <li><a href=\"https://seekingalpha.com/pr/17243047-seven-stars-cloud-reports-solid-second-quarter-operating-results-exceeds-full-year-2018-top\" target=\"_blank\">Press release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3382042\" data-linked=\"Seven Stars Cloud -6.5% after spending widens loss\" data-tweet=\"$SSC-OLD - Seven Stars Cloud -6.5% after spending widens loss https://seekingalpha.com/news/3382042-seven-stars-cloudminus-6_5-after-spending-widens-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3382042-seven-stars-cloudminus-6_5-after-spending-widens-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:49 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382041\" data-ts=\"1534171232\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAD\" target=\"_blank\">RAD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382041-rite-aidminus-8-after-cowen-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Rite Aid -8% after Cowen cut</a></h4><ul> <li>Shares of Rite Aid (NYSE:<a href='https://seekingalpha.com/symbol/RAD' title='Rite Aid Corporation'>RAD</a>) are <font color='red'>down 7.77%</font> after Cowen lowers its rating to Market Perform from Outperform and sets a price target of $1.50.</li> <li>Analyst Charles Rhyee sees Rite Aid shares as fairly valued by the market following the collapse of the Albertson's merger.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3382041\" data-linked=\"Rite Aid -8% after Cowen cut\" data-tweet=\"$RAD - Rite Aid -8% after Cowen cut https://seekingalpha.com/news/3382041-rite-aidminus-8-after-cowen-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3382041-rite-aidminus-8-after-cowen-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>142&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382040\" data-ts=\"1534171211\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RWLK\" target=\"_blank\">RWLK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382040-rewalk-robotics-up-14-after-news-coverage\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ReWalk Robotics up 14% after news coverage</a></h4><ul><li>Nano cap ReWalk Robotics (<a href='https://seekingalpha.com/symbol/RWLK' title='ReWalk Robotics'>RWLK</a> <font color='green'>+13.7%</font>) is up on almost triple normal volume in the early going. Yesterday morning, CBS' Sunday Morning show <a href=\"https://www.cbsnews.com/news/robotic-exoskeletons-helping-paraplegics-walk-again/\" target=\"_blank\">featured </a>its exoskeletons and how they are helping paraplegics walk again.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382040\" data-linked=\"ReWalk Robotics up 14% after news coverage\" data-tweet=\"$RWLK - ReWalk Robotics up 14% after news coverage https://seekingalpha.com/news/3382040-rewalk-robotics-up-14-after-news-coverage?source=tweet\" data-url=\"https://seekingalpha.com/news/3382040-rewalk-robotics-up-14-after-news-coverage\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382038\" data-ts=\"1534170633\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XBIO\" target=\"_blank\">XBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382038-xenetic-bio-up-32\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Xenetic Bio up 32%</a></h4><ul><li>Nano cap Xenetic Biosciences (<a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a> <font color='green'>+31.6%</font>) is up more than a 6x surge in volume early in the session. No particular news accounts for the action.</li><li>On Friday, August 10, after the close it filed its Q2 report. At quarter-end, it had ~$3.3M in cash. Operations consumed $3.8M in H1.</li><li>On <a href=\"https://www.sec.gov/Archives/edgar/data/1534525/000168316818002256/xenetic_10q-063018.htm#a4\" target=\"_blank\">page 16</a> in the 10-Q, it states that it \"will need to raise additional capital or pursue other strategic alternatives in the very near term in order to continue the pursuit of our business plan and continue as a going concern.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3382038\" data-linked=\"Xenetic Bio up 32%\" data-tweet=\"$XBIO - Xenetic Bio up 32% https://seekingalpha.com/news/3382038-xenetic-bio-up-32?source=tweet\" data-url=\"https://seekingalpha.com/news/3382038-xenetic-bio-up-32\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:30 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382034\" data-ts=\"1534170262\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BADFF\" target=\"_blank\">BADFF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382034-badger-daylighting-up-3_4-post-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Badger Daylighting up 3.4% post Q2 results</a></h4><ul><li>Badger Daylighting (<a href='https://seekingalpha.com/symbol/BADFF' title='Badger Daylighting Ltd.'>OTCPK:BADFF</a>)&nbsp;<a href=\"https://seekingalpha.com/pr/17243011-badger-daylighting-ltd-announces-record-second-quarter-financial-results\" target=\"_blank\">reports Q2</a>&nbsp;revenue growth of 19.3% Y/Y to $147.6M, of which Hydrovac service of $123.2M (+15.8% Y/Y); Other service revenue of $23.8M (+40% Y/Y) &amp; Truck placement revenue of $0.52M (+85.7% Y/Y).</li><li>Gross margin<font color='green'>&nbsp;increased&nbsp;250 bps</font>&nbsp;to 32.1%,</li><li>Adj. EBITDA margin&nbsp;<font color='green'>increased&nbsp;13 bps</font>&nbsp;to 26.1% which was driven by revenue growth, higher hydrovac utilization and direct operating expense management, offset by higher G&amp;A costs.</li><li>Revenue per truck per month&nbsp;was $30,300 (+3.8% Y/Y).</li><li>The company added 36 net incremental hydrovacs in Q2 and reaffirmed its anticipated hydrovac build rate for 2018 &amp; also had 1,190 hydrovacs in operation.</li><li>Total debt less cash and equivalents was $61.5M, with a corresponding total debt less cash and equivalents to compliance EBITDA ratio of 0.5X.</li><li><strong>2018 Outlook:</strong> Badger anticipates total hydrovac build for fiscal 2018 will be ~160-200 units with anticipated retirements of 60-80 units; Adj. EBITDA margin of 28-29%; drive fleet utilization and revenue per truck per month above $30,000.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3381907-badger-daylighting-reports-q2-results\" target=\"_blank\">Badger Daylighting reports Q2 results</a> (Aug. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3382034\" data-linked=\"Badger Daylighting up 3.4% post Q2 results\" data-tweet=\"$BADFF - Badger Daylighting up 3.4% post Q2 results https://seekingalpha.com/news/3382034-badger-daylighting-up-3_4-post-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3382034-badger-daylighting-up-3_4-post-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:24 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382032\" data-ts=\"1534170198\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HPJ\" target=\"_blank\">HPJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382032-on-highpower-internationals-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Highpower International&#39;s Q2 results</a></h4><ul><li>Highpower International (<a href='https://seekingalpha.com/symbol/HPJ' title='Highpower International, Inc.'>HPJ</a> <font color='green'>+1.4%</font>) reported Q2 sales growth of 25.6% Y/Y to $64.9M, with Lithium business up by 31.1% Y/Y and Ni-MH business up by 39.3% Y/Y.</li><li>Q2 Gross margin&nbsp;<font color='red'>declined by 593 bps</font>&nbsp;to 17.4%, due to high raw material prices; and operating margin&nbsp;<font color='red'>declined by 388 b</font><font color='red'>ps</font>&nbsp;to 5.2%.</li><li>EBITDA was $4.96M (-23.7% Y/Y) and margin&nbsp;<font color='red'>declined by 196 bps</font>&nbsp;to 7.6%.</li><li>Q2 Expenses: R&amp;D $3.59M (+68.1% Y/Y); Selling &amp; distribution $2.12M (+23.1% Y/Y) and G&amp;A $3.91M (+29.6% Y/Y).</li><li>Net cash flows used by operating activities was $7.64M compared to $0.14M cash provided a year ago.</li><li>Company had Cash and restricted cash $37.44M as of June 30, 2018.</li><li>3Q18 Outlook: Revenue growth of 30% Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3381895-highpower-international-reports-q2-results\" target=\"_blank\">Highpower International reports Q2 results</a> (Aug. 13)</li></ul><div class=\"tiny-share-widget\" data-id=\"3382032\" data-linked=\"More on Highpower International&#39;s Q2 results\" data-tweet=\"$HPJ - More on Highpower International&#39;s Q2 results https://seekingalpha.com/news/3382032-on-highpower-internationals-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3382032-on-highpower-internationals-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:23 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382030\" data-ts=\"1534169558\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BEDU\" target=\"_blank\">BEDU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382030-education-sector-rattled-rule-change-in-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Education sector rattled by rule change in China</a></h4><ul> <li>Education stocks are being thrashed around in early trading after China's Ministry of Justice posted a draft amendment to private education rules that could limit M&amp;A activity.</li> <li>The news from China is impacting for-profit names in the U.S. and China.</li> <li>Decliners: Bright Scholar (<a href='https://seekingalpha.com/symbol/BEDU' title='Bright Scholar Education'>BEDU</a> <font color='red'>-25.1%</font>), New Oriental Education &amp; Technology (<a href='https://seekingalpha.com/symbol/EDU' title='New Oriental Education & Technology Group Inc.'>EDU</a> <font color='red'>-1.9%</font>), TAL Education (<a href='https://seekingalpha.com/symbol/TAL' title='TAL Education Group'>TAL</a> <font color='red'>-2.5%</font>), RISE Education Cayman (<a href='https://seekingalpha.com/symbol/REDU' title='RISE Education Cayman Ltd'>REDU</a> <font color='red'>-0.5%</font>), RYB Education (<a href='https://seekingalpha.com/symbol/RYB' title='RYB Education'>RYB</a> <font color='red'>-3%</font>), Puxin Limited (<a href='https://seekingalpha.com/symbol/NEW' title='Puxin'>NEW</a> <font color='red'>-3.7%</font>), Sunlands Online Education (<a href='https://seekingalpha.com/symbol/STG' title='Sunlands Online Education'>STG</a> <font color='red'>-6.5%</font>), Four Seasons Education (<a href='https://seekingalpha.com/symbol/FEDU' title='Four Seasons Education &#40;Cayman&#41; Inc.'>FEDU</a> <font color='red'>-2.3%</font>) and American Public Education (<a href='https://seekingalpha.com/symbol/APEI' title='American Public Education, Inc.'>APEI</a> <font color='red'>-1.7%</font>).</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3382030\" data-linked=\"Education sector rattled by rule change in China\" data-tweet=\"$BEDU $BEDU $EDU - Education sector rattled by rule change in China https://seekingalpha.com/news/3382030-education-sector-rattled-rule-change-in-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3382030-education-sector-rattled-rule-change-in-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382022\" data-ts=\"1534168768\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNRX\" target=\"_blank\">VNRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382022-volitionrx-up-14-on-encouraging-data-on-nu-q-in-prostate-cancer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VolitionRx up 14% on encouraging data on Nu.Q in prostate cancer</a></h4><ul><li>Thinly traded nano cap VolitionRx Limited (<a href='https://seekingalpha.com/symbol/VNRX' title='VolitionRX Ltd'>VNRX</a> <font color='green'>+13.6%</font>) is up almost a 7x surge in volume in response to its <a href=\"https://seekingalpha.com/pr/17243202-preliminary-data-study-demonstrates-94-percent-accuracy-detecting-aggressive-prostate-cancer\" target=\"_blank\">announcement </a>of positive data from a proof-of-concept study evaluating its Nu.Q assays for the diagnosis of high-grade prostate cancer.</li><li>The company's five-assay panel correctly identified 94% (sensitivity) of the cancers that required treatment while correctly identifying 84% of true negatives (specificity). The company says the 94% sensitivity handily beat 33% for PSA (prostate-specific antigen) alone.</li><li>Larger studies are being planned.</li></ul><div class=\"tiny-share-widget\" data-id=\"3382022\" data-linked=\"VolitionRx up 14% on encouraging data on Nu.Q in prostate cancer\" data-tweet=\"$VNRX - VolitionRx up 14% on encouraging data on Nu.Q in prostate cancer https://seekingalpha.com/news/3382022-volitionrx-up-14-on-encouraging-data-on-nu-q-in-prostate-cancer?source=tweet\" data-url=\"https://seekingalpha.com/news/3382022-volitionrx-up-14-on-encouraging-data-on-nu-q-in-prostate-cancer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382021\" data-ts=\"1534168321\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382021-piper-jaffray-amazon-ad-revenue-top-16b-in-two-years\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray: Amazon ad revenue could top $16B in two years</a></h4><ul><li>        Piper Jaffray analyst Michael Olson <a href=\"https://www.marketwatch.com/story/amazons-ad-business-to-be-a-major-driver-topping-aws-profits-by-2020-2018-08-13?siteid=bulletrss\" target=\"_blank\">thinks</a> Amazon&rsquo;s (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) ad revenue will reach $8B this year, contributing $3B to operating profit.</li><li>        The analyst expects ad revenue of $16B by 2020 and thinks the profits could exceed those from Amazon Web Services by 2021.</li><li>               Olson reiterates Amazon at an Overweight rating with a $2,100 price target.&nbsp;</li><li>                  Amazon shares are&nbsp;<font color='green'>up 1.1%</font>&nbsp;to $1,907.44.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3374549-amazon-plus-3_2-percent-q2-eps-beat-49-percent-aws-growth\" target=\"_blank\">Amazon +3.2% on Q2 EPS beat, 49% AWS growth</a> (July 26)</li></ul><div class=\"tiny-share-widget\" data-id=\"3382021\" data-linked=\"Piper Jaffray: Amazon ad revenue could top $16B in two years\" data-tweet=\"$AMZN - Piper Jaffray: Amazon ad revenue could top $16B in two years https://seekingalpha.com/news/3382021-piper-jaffray-amazon-ad-revenue-top-16b-in-two-years?source=tweet\" data-url=\"https://seekingalpha.com/news/3382021-piper-jaffray-amazon-ad-revenue-top-16b-in-two-years\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>19&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382017\" data-ts=\"1534167941\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/YY\" target=\"_blank\">YY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382017-yyminus-1_1-morgan-stanley-warns-ahead-of-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">YY -1.1% as Morgan Stanley warns ahead of earnings</a></h4><ul>    <li><a href='https://seekingalpha.com/symbol/YY' title='YY Inc.'>YY</a> is <font color='red'>1.1% lower</font> this morning after Morgan Stanley trims its price target ahead of earnings set to come after today's market close.</li>    <li>The firm's sounding cautious notes about increasing risk into 2019, and cutting its target to a Street-low $90 from $106, implying just 2% upside.</li>    <li>Revenue growth has the potential to turn negative during the year, MS says -- a turn that has been accelerating as short-video rivals launch more live streaming features and partner up with talent agencies. It's expecting lower EBITDA and for more downward earnings revisions if the Q3 revenue forecast is weak. (h/t <a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">Notable Calls</a>)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3382017\" data-linked=\"YY -1.1% as Morgan Stanley warns ahead of earnings\" data-tweet=\"$YY - YY -1.1% as Morgan Stanley warns ahead of earnings https://seekingalpha.com/news/3382017-yyminus-1_1-morgan-stanley-warns-ahead-of-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3382017-yyminus-1_1-morgan-stanley-warns-ahead-of-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382006\" data-ts=\"1534166826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSG\" target=\"_blank\">INSG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382006-inseegoplus-3_3-after-golden-harbor-takes-12_5-stake\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Inseego +3.3% after Golden Harbor takes 12.5% stake</a></h4><ul>   <li>Telematics firm Inseego (NASDAQ:<a href='https://seekingalpha.com/symbol/INSG' title='Inseego Corp.'>INSG</a>) is <font color='green'>up 3.3%</font> premarket, in early action after a weekend disclosure by Golden Harbor of a <a href=\"https://seekingalpha.com/filing/4134027\" target=\"_blank\">12.5% stake</a> in the company.</li>    <li>Joe Lewis' firm and other investors entered into a purchase agreement with Inseego on Aug. 6 for 12,062,000 units, each consisting of a share of common stock and a warrant to acquire 0.35 of a share, at a price of $1.63/unit.</li>    <li>Golden Harbor took 9,046,500 units for a total of $14,745,795.</li>    <li>It has the right to designate a member of Inseego's board, and will be able to designate an additional member if its stake goes over 20%.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3382006\" data-linked=\"Inseego +3.3% after Golden Harbor takes 12.5% stake\" data-tweet=\"$INSG - Inseego +3.3% after Golden Harbor takes 12.5% stake https://seekingalpha.com/news/3382006-inseegoplus-3_3-after-golden-harbor-takes-12_5-stake?source=tweet\" data-url=\"https://seekingalpha.com/news/3382006-inseegoplus-3_3-after-golden-harbor-takes-12_5-stake\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382002\" data-ts=\"1534166460\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JKS\" target=\"_blank\">JKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382002-jinkosolar-reports-below-consensus-q2-results-maintains-shipment-view\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JinkoSolar reports below-consensus Q2 results but maintains shipment view</a></h4><ul>     <li>JinkoSolar (NYSE:<a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>) <font color='red'>-6.5%</font> premarket after reporting weaker than expected <a href=\"https://seekingalpha.com/news/3381903-jinkosolar-holding-misses-0_14-beats-revenue\" target=\"_blank\">Q2 earnings</a> and a 21% Y/Y decline in revenues.</li>     <li>JKS says solar module shipments during Q2 totaled 2,794 MW (including 200 MW  to the company's overseas downstream segment for which no revenue was recognized), up 38.7% from 2,015 MW in Q1 but 3% lower than 2,884 MW reported in the year-ago quarter.</li>     <li>But JKS reports a <a href=\"https://www.pv-tech.org/news/jinkosolar-claims-immunity-from-industry-woes-as-2018-shipment-guidance-rem\" target=\"_blank\">lower gross margin of 12%</a> due to a decline in the average selling price of PV panels, compared with 14.4%  in Q1.</li>     <li>JKS maintains its full-year shipment outlook of 11.5-12 GW while forecasting Q3 total solar module  shipments of 2.8-3.0 GW.</li><li>The company believes the Chinese government's new policies will have a \"relatively limited impact\" on its operations over the short term, and says \"good visibility of our order book for the entire year which is  predominantly made up of overseas orders to markets which are growing  rapidly and will generate significant opportunities ahead.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3382002\" data-linked=\"JinkoSolar reports below-consensus Q2 results but maintains shipment view\" data-tweet=\"$JKS - JinkoSolar reports below-consensus Q2 results but maintains shipment view https://seekingalpha.com/news/3382002-jinkosolar-reports-below-consensus-q2-results-maintains-shipment-view?source=tweet\" data-url=\"https://seekingalpha.com/news/3382002-jinkosolar-reports-below-consensus-q2-results-maintains-shipment-view\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3382001\" data-ts=\"1534166442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ABIL\" target=\"_blank\">ABIL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3382001-premarket-gainers-of-9-05-08-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (08/13/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/ABIL' title='Ability Inc.'>ABIL</a> <font color='green'>+44%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings N.V.'>NLSN</a> <font color='green'>+16%</font>&nbsp;as Elliott <a href=\"https://seekingalpha.com/news/3381971-elliott-confirms-active-stake-nielsen-sale-push\" target=\"_blank\">confirms</a> active stake in Nielsen.</li>     <li><a href='https://seekingalpha.com/symbol/XBIO' title='Xenetic Biosciences, Inc.'>XBIO</a> <font color='green'>+15%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/DBD' title='Diebold Nixdorf'>DBD</a> <font color='green'>+14%</font>&nbsp;on lender, monetization <a href=\"https://seekingalpha.com/news/3381963-diebold-nixdorf-plus-8_9-percent-lender-monetization-updates\" target=\"_blank\">updates</a>.</li>     <li><a href='https://seekingalpha.com/symbol/IZEA' title='IZEA Worldwide, Inc.'>IZEA</a> <font color='green'>+12%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/VNRX' title='VolitionRX Ltd'>VNRX</a> <font color='green'>+17%</font>&nbsp;on 94% <a href=\"https://seekingalpha.com/pr/17243202-preliminary-data-study-demonstrates-94-percent-accuracy-detecting-aggressive-prostate-cancer\" target=\"_blank\">accuracy</a> detecting aggressive prostate cancer.</li>     <li><a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a> <font color='green'>+8%</font>&nbsp;as CLR 131 <a href=\"https://seekingalpha.com/news/3381975-cellectar-bios-clr-131-nabs-rpdd-status-rare-pediatric-cancer-shares-16-percent-premarket\" target=\"_blank\">nabs</a> RPDD status for rare pediatric cancer.</li>     <li><a href='https://seekingalpha.com/symbol/NVFY' title='Nova Lifestyle, Inc.'>NVFY</a> <font color='green'>+7%</font>&nbsp;on Q2 <a href=\"https://seekingalpha.com/news/3381931-nova-lifestyle-reports-q2-results\" target=\"_blank\">result</a>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3382001\" data-linked=\"Premarket Gainers as of 9:05 am (08/13/2018)\" data-tweet=\"$ABIL $ABIL $NLSN - Premarket Gainers as of 9:05 am (08/13/2018) https://seekingalpha.com/news/3382001-premarket-gainers-of-9-05-08-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3382001-premarket-gainers-of-9-05-08-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3381998\" data-ts=\"1534166189\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DY\" target=\"_blank\">DY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3381998-premarket-losers-of-9-05-8-13-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (8/13/2018)</a></h4><ul><li><a href='https://seekingalpha.com/symbol/DY' title='Dycom Industries Inc.'>DY</a>&nbsp;<font color='red'>-21%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3381936-dycom-minus-21-percent-steep-cuts-quarterly-full-year-guidance\" target=\"_blank\">cutting</a> quarterly and full-year guidance.</li><li><a href='https://seekingalpha.com/symbol/BEDU' title='Bright Scholar Education'>BEDU</a> <font color='red'>-19%</font>.</li><li><a href='https://seekingalpha.com/symbol/RYB' title='RYB Education'>RYB</a> <font color='red'>-12%</font>.</li><li><a href='https://seekingalpha.com/symbol/TKC' title='Turkcell Iletisim Hizmetleri A.S.'>TKC</a> <font color='red'>-10%</font>.</li><li><a href='https://seekingalpha.com/symbol/NEW' title='Puxin'>NEW</a> <font color='red'>-10%</font>.</li><li><a href='https://seekingalpha.com/symbol/AWX' title='Avalon Holdings Corporation'>AWX</a> <font color='red'>-9%</font>.</li><li><a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3381914-seven-stars-cloud-reports-q2-results\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/JKS' title='JinkoSolar Holding Co., Ltd.'>JKS</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3381903-jinkosolar-holding-misses-0_14-beats-revenue\" target=\"_blank\">Q2 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/GEMP' title='Gemphire Therapeutics'>GEMP</a>&nbsp;<font color='red'>-6%</font>&nbsp;after analyst <a href=\"https://seekingalpha.com/news/3381930-premarket-analyst-action-healthcare\" target=\"_blank\">downgrade</a>.</li><li><a href='https://seekingalpha.com/symbol/TAL' title='TAL Education Group'>TAL</a>&nbsp;<font color='red'>-5%</font>&nbsp;after <a href=\"https://seekingalpha.com/news/3381985-portfolio-moves-greenwoods-asset-management\" target=\"_blank\">portfolio</a> moves by Greenwoods Asset Management</li><li><a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a>&nbsp;<font color='red'>-5%</font>&nbsp;after FDA <a href=\"https://seekingalpha.com/pr/17243221-arbutus-lnp-licensee-alnylam-announces-fda-approval-onpattro-patisiran-treatment-attr\" target=\"_blank\">approved</a> NDA for ONPATTRO.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3381998\" data-linked=\"Premarket Losers as of 9:05 am (8/13/2018)\" data-tweet=\"$DY $DY $BEDU - Premarket Losers as of 9:05 am (8/13/2018) https://seekingalpha.com/news/3381998-premarket-losers-of-9-05-8-13-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3381998-premarket-losers-of-9-05-8-13-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:16 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3381997\" data-ts=\"1534166094\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3381997-u-s-holds-up-global-equities-struggle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. holds up as global equities struggle</a></h4><ul><li>This just in: Ex-U.S., stock markets across the world are having a tough time of it.&nbsp;That emerging markets are faring worst - amid Fed tightening, trade tensions, and Turkey's meltdown - isn't exactly new news, but developed markets have seen sizable drawdowns as well.</li><li>Breaking it down, <a href=\"https://twitter.com/Convertbond/status/1028988051949797376\" target=\"_blank\">Lawrence McDonald notes</a> Canada is&nbsp;<font color='red'>down 6.1%</font>&nbsp;from its 2018 high, and Japan, Germany, and the U.K. are all&nbsp;<font color='red'>off about 10%</font>. The S&amp;P 500? It's&nbsp;<font color='red'>down just 1.6%</font>.</li><li>Turkey leads decliners among emerging markets,<font color='red'> lower by 56%</font>, with Brazil&nbsp;<font color='red'>down 29%</font>, Argentina&nbsp;<font color='red'>26%</font>, China&nbsp;<font color='red'>22%</font>, Russia&nbsp;<font color='red'>19.7%</font>, and Mexico&nbsp;<font color='red'>14.1%</font>.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EFA' title='iShares MSCI EAFE ETF'>EFA</a>, <a href='https://seekingalpha.com/symbol/VEA' title='Vanguard FTSE Developed Markets ETF'>VEA</a>, <a href='https://seekingalpha.com/symbol/GAB' title='Gabelli Equity Trust'>GAB</a>, <a href='https://seekingalpha.com/symbol/IEFA' title='iShares Core MSCI EAFE ETF'>IEFA</a>, <a href='https://seekingalpha.com/symbol/DBEF' title='Deutsche X-trackers MSCI EAFE Hedged Equity ETF'>DBEF</a>, <a href='https://seekingalpha.com/symbol/URTH' title='iShares MSCI World ETF'>URTH</a>, <a href='https://seekingalpha.com/symbol/DZK' title='Direxion Daily Developed Markets Bull 3x Shares ETF'>DZK</a>, <a href='https://seekingalpha.com/symbol/HEFA' title='iShares Currency Hedged MSCI EAFE ETF'>HEFA</a>, <a href='https://seekingalpha.com/symbol/EFZ' title='ProShares Short MSCI EAFE ETF'>EFZ</a>, <a href='https://seekingalpha.com/symbol/DPK' title='Direxion Daily Developed Markets Bear 3x Shares ETF'>DPK</a>, <a href='https://seekingalpha.com/symbol/EFU' title='ProShares UltraShort MSCI EAFE ETF'>EFU</a>, <a href='https://seekingalpha.com/symbol/EFO' title='ProShares Ultra MSCI EAFE ETF'>EFO</a>, <a href='https://seekingalpha.com/symbol/ADRD' title='Invesco BLDRS Developed Markets 100 ADR Index ETF'>ADRD</a>, <a href='https://seekingalpha.com/symbol/KLDW' title='Gavekal Knowledge Leaders Developed World ETF'>KLDW</a>, <a href='https://seekingalpha.com/symbol/FDT' title='First Trust Developed Markets Ex-US AlphaDEX ETF'>FDT</a>, <a href='https://seekingalpha.com/symbol/MFLA' title='iPath Long Enhanced 2x MSCI EAFE Index ETN'>MFLA</a>, <a href='https://seekingalpha.com/symbol/HFXI' title='IQ 50 Percent Hedged FTSE International ETF'>HFXI</a>, <a href='https://seekingalpha.com/symbol/RODM' title='Hartford Multifactor Developed Markets &#40;ex-US&#41; ETF'>RODM</a>, <a href='https://seekingalpha.com/symbol/ESGD' title='iShares MSCI EAFE ESG Select ETF'>ESGD</a>, <a href='https://seekingalpha.com/symbol/DDBI' title='Legg Mason Developed ex-US Diversified Core ETF'>DDBI</a>, <a href='https://seekingalpha.com/symbol/IDHQ' title='Invesco S&P International Developed Quality Portfolio ETF'>IDHQ</a>, <a href='https://seekingalpha.com/symbol/RFDI' title='First Trust RiverFront Dynamic Developed International ETF'>RFDI</a>, <a href='https://seekingalpha.com/symbol/FWDI' title='AdvisorShares Madrona International ETF'>FWDI</a>, <a href='https://seekingalpha.com/symbol/DEFA' title='iShares Adaptive Currency Hedged MSCI EAFE ETF'>DEFA</a>, <a href='https://seekingalpha.com/symbol/IDEV' title='iShares Core MSCI International Developed Markets ETF'>IDEV</a>, <a href='https://seekingalpha.com/symbol/BRGL' title='Bernstein Global Research ETF'>BRGL</a>, <a href='https://seekingalpha.com/symbol/PPDM' title='Direxion Portfolio+ Developed Markets ETF'>PPDM</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3381997\" data-linked=\"U.S. holds up as global equities struggle\" data-tweet=\"$EFA $VEA $GAB - U.S. holds up as global equities struggle https://seekingalpha.com/news/3381997-u-s-holds-up-global-equities-struggle?source=tweet\" data-url=\"https://seekingalpha.com/news/3381997-u-s-holds-up-global-equities-struggle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:14 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3381993\" data-ts=\"1534165546\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MDXG\" target=\"_blank\">MDXG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3381993-nasdaq-grants-listing-extension-to-mimedx-hearing-next-month-shares-up-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nasdaq grants listing extension to MiMedx, hearing next month; shares up 1% premarket</a></h4><ul><li>MiMedx (<a href='https://seekingalpha.com/symbol/MDXG' title='MiMedx Group Inc.'>OTC:MDXG</a>) is up&nbsp;<font color='green'>1%&nbsp;</font>premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17243129-mimedx-announces-nasdaq-listing-extension-hearing-date\" target=\"_blank\">announcement </a>that Nasdaq has granted its request for a listing extension. A hearing is scheduled for September 13 during which the company will present its plan to regain compliance with the listing rule for timely filing of periodic reports with the SEC.</li></ul><div class=\"tiny-share-widget\" data-id=\"3381993\" data-linked=\"Nasdaq grants listing extension to MiMedx, hearing next month; shares up 1% premarket\" data-tweet=\"$MDXG - Nasdaq grants listing extension to MiMedx, hearing next month; shares up 1% premarket https://seekingalpha.com/news/3381993-nasdaq-grants-listing-extension-to-mimedx-hearing-next-month-shares-up-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3381993-nasdaq-grants-listing-extension-to-mimedx-hearing-next-month-shares-up-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3381990\" data-ts=\"1534165415\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HNHAF\" target=\"_blank\">HNHAF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3381990-foxconn-reports-q2-net-profit-drop-misses-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Foxconn reports Q2 net profit drop that misses estimates</a></h4><ul><li>        Foxconn (<a href='https://seekingalpha.com/symbol/HNHAF' title='Hon Hai Precision Industry Co. Ltd.'>OTCPK:HNHAF</a>, HNHAY) <a href=\"https://www.wsj.com/articles/foxconn-posts-unexpected-drop-in-profit-1534163275?mod=rss_Technology\" target=\"_blank\">reports</a> a 2.2% decline in Q2 profit despite Apple (NASDAQ:<a href='https://seekingalpha.com/symbol/AAPL' title='Apple Inc.'>AAPL</a>) reporting positive iPhone demand.</li><li>               Foxconn Q2 net profit was NT17.5B (consensus: NT$20.2B) with revenue up 17% Y/Y to NT$1.08T.&nbsp;</li><li>               Apple accounted for about 54% of Foxconn revenue last year. The tech giant should announce its new lineup of three iPhones in September. &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3376283-apple-plus-2_4-percent-q3-beats-services-time-high\" target=\"_blank\">Apple +2.4% on Q3 beats with Services at all-time high</a> (July 31)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3362084-apple-supplier-foxconn-plans-new-business-focuses\" target=\"_blank\">Apple supplier Foxconn plans new business focuses</a> (June 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3381990\" data-linked=\"Foxconn reports Q2 net profit drop that misses estimates\" data-tweet=\"$HNHAF $HNHAF $HNHPD - Foxconn reports Q2 net profit drop that misses estimates https://seekingalpha.com/news/3381990-foxconn-reports-q2-net-profit-drop-misses-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3381990-foxconn-reports-q2-net-profit-drop-misses-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3381983\" data-ts=\"1534165133\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ASNS\" target=\"_blank\">ASNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3381983-arsanis-down-6-premarket-on-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Arsanis down 6% premarket on Q2 results</a></h4><ul><li>Arsanis (<a href='https://seekingalpha.com/symbol/ASNS' title='Arsanis, Inc.'>ASNS</a>) <a href=\"https://seekingalpha.com/pr/17243153-arsanis-reports-financial-results-second-quarter-2018\" target=\"_blank\">Q2 results</a>: Revenues: $0; R&amp;D Expense: $8.9M; SG&amp;A: $3.7M; Net Loss: ($12.1M) (-112.3%); Loss Per Share: ($0.85) (+92.4%).</li><li>The outcome of the interim analysis of ASN100 Phase 2 clinical trial was disappointing as the trial failed to meet the primary endpoints and recommended that the trial be discontinued. The Company expects to complete the evaluation in Q4.</li><li>Also, Arsanis have ceased further clinical development of ASN100, pending the results of the analysis.</li><li>Shares are down&nbsp;<font color='red'>6%</font>&nbsp;premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3381983\" data-linked=\"Arsanis down 6% premarket on Q2 results\" data-tweet=\"$ASNS $XFOR - Arsanis down 6% premarket on Q2 results https://seekingalpha.com/news/3381983-arsanis-down-6-premarket-on-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3381983-arsanis-down-6-premarket-on-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:58 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3381982\" data-ts=\"1534165055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOLD\" target=\"_blank\">FOLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3381982-amicus-prices-galafold-315k-for-fabry-shares-up-3-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amicus prices Galafold at $315K for Fabry; shares up 3% premarket</a></h4><ul><li>Endpoints News' John Carroll <a href=\"https://endpts.com/once-stiff-armed-at-the-fda-new-management-offers-amicus-a-warm-embrace-and-marketing-ok-for-galafold/\" target=\"_blank\">reports </a>that Amicus Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/FOLD' title='Amicus Therapeutics, Inc.'>FOLD</a>) has priced Galafold (migalastat) at $315K per year for the treatment of Fabry disease.</li><li>Shares are up&nbsp;<font color='red'>3%</font>&nbsp;premarket on light volume.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3381795-fda-oks-amicus-galafold-fabry\" target=\"_blank\">FDA OK's Amicus' Galafold for Fabry</a> (Aug. 10)</li></ul><div class=\"tiny-share-widget\" data-id=\"3381982\" data-linked=\"Amicus prices Galafold at $315K for Fabry; shares up 3% premarket\" data-tweet=\"$FOLD - Amicus prices Galafold at $315K for Fabry; shares up 3% premarket https://seekingalpha.com/news/3381982-amicus-prices-galafold-315k-for-fabry-shares-up-3-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3381982-amicus-prices-galafold-315k-for-fabry-shares-up-3-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3381975\" data-ts=\"1534164377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CLRB\" target=\"_blank\">CLRB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3381975-cellectar-bios-clr-131-nabs-rpdd-status-for-rare-pediatric-cancer-shares-up-16-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cellectar Bio&#39;s CLR 131 nabs RPDD status for rare pediatric cancer; shares up 16% premarket</a></h4><ul><li>Cellectar Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CLRB' title='Cellectar Biosciences, Inc.'>CLRB</a>) is up&nbsp;<font color='green'>16%</font>&nbsp;premarket on average volume in response to its announcement that the FDA has granted Rare Pediatric Disease Designation &#40;RPDD&#41; to CLR 131 for <a href=\"https://www.webmd.com/cancer/ewings-sarcoma#1\" target=\"_blank\">Ewing's sarcoma</a>, a rare pediatric cancer that grows in the bones or soft tissue.</li><li>If approved for the indication, the company will receive a Rare Pediatric Disease Priority Review voucher that can be used for a future marketing application or it can be sold to a third party.</li></ul><div class=\"tiny-share-widget\" data-id=\"3381975\" data-linked=\"Cellectar Bio&#39;s CLR 131 nabs RPDD status for rare pediatric cancer; shares up 16% premarket\" data-tweet=\"$CLRB - Cellectar Bio&#39;s CLR 131 nabs RPDD status for rare pediatric cancer; shares up 16% premarket https://seekingalpha.com/news/3381975-cellectar-bios-clr-131-nabs-rpdd-status-for-rare-pediatric-cancer-shares-up-16-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3381975-cellectar-bios-clr-131-nabs-rpdd-status-for-rare-pediatric-cancer-shares-up-16-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3381971\" data-ts=\"1534163881\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NLSN\" target=\"_blank\">NLSN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3381971-elliott-confirms-active-stake-in-nielsen-sale-push\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Elliott confirms active stake in Nielsen, sale push</a></h4><ul><li>Elliott Associates <a href=\"https://seekingalpha.com/filing/4134852\" target=\"_blank\">confirms</a> its 8.4% active stake in Nielsen Holdings (NYSE:<a href='https://seekingalpha.com/symbol/NLSN' title='Nielsen Holdings N.V.'>NLSN</a>).</li><li>Elliott wants to engage in a dialogue with the board and/or management about strategic opportunities including a potential sale of assets or the business.</li><li>Nielsen shares are<font color='green'>&nbsp;up 15.9%</font>&nbsp;premarket to $25.47.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3381853-wsj-elliott-takes-8-percent-nielsen-plans-push-sale\" target=\"_blank\">WSJ: Elliott takes 8% of Nielsen, plans push for sale</a> (Aug. 12)</li><li>Update to clarify stake: Elliott has a 5.1% stake in Nielsen and an 8.4% economic interest in the company's outstanding common shares including derivatives and stock options.</li><li>Nielsen <a href=\"https://www.reuters.com/article/us-nielsen-holdings-m-a-elliott/elliott-urges-sale-of-nielsen-after-taking-stake-idUSKBN1KY1EA\" target=\"_blank\">tells Reuters</a> that it regularly engages with shareholders and welcomes the views and perspectives of owners including Elliott.</li></ul><div class=\"tiny-share-widget\" data-id=\"3381971\" data-linked=\"Elliott confirms active stake in Nielsen, sale push\" data-tweet=\"$NLSN - Elliott confirms active stake in Nielsen, sale push https://seekingalpha.com/news/3381971-elliott-confirms-active-stake-in-nielsen-sale-push?source=tweet\" data-url=\"https://seekingalpha.com/news/3381971-elliott-confirms-active-stake-in-nielsen-sale-push\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:38 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}